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ABSTRACT 
OBJECTIVES 
1. To study the age and sex distribution among patients presenting with Salivary 
Gland Swellings. 
2. To study the mode of clinical presentation of various Salivary Gland Swellings. 
3. To study the accuracy of Fine Needle Aspiration Cytology (FNAC) in the 
diagnosis of Salivary Gland Swellings. 
4. To study the methods of current surgical treatments of Salivary Gland Swellings. 
BACKGROUND DATA 
 Salivary Gland Swellings are one of the most common clinical conditions 
encountered by the general surgeon. There are various causes of salivary swellings and 
they arouse much interest and debate because of their remarkable variability in structure, 
clinical presentation and behavior. This study was done with a interest to know the 
incidence, clinical presentation of swellings of the salivary glands, management, 
complications and correlation of the FNAC with the histopathology. 
METHODOLOGY 
 50 cases of salivary gland swellings presenting to Surgery Dept. and Surgical 
Oncology Dept. of Govt. Royapettah Hospital and Surgery Dept. of KMC Hospital at 
Chennai, from November 2014 to August 2015 were prospectively studied. Age, Sex 
distribution, mode of clinical presentation would be entered in the proforma. Also 
correlation of FNAC with histopathological findings would be analysed. The various 
treatment options of different etiologies of Salivary Gland Swellings will also be studied. 
RESULTS 
 Salivary gland swelling occurred more commonly in 3rd and 4th decades of life 
(28.57%) and 65% of salivary swellings were present in females. All patients presented 
with salivary gland swelling (100%), 65% of patients presented with pain and 55% of 
patients presented with tenderness. Among the non inflammatory and neoplastic 
swellings, 65% of salivary swellings were neoplastic and 35% non inflammatory 
swellings. Among non inflammatory swellings 80% was sialolithiasis and 20% was 
ranula. 100% of sialolithiasis were present in submandibular salivary glands. 100% of 
ranula was present in sublingual salivary glands. Among the neoplastic swellings, 100% 
of the neoplastic swellings were present in parotid glands. FNAC has overall diagnostic 
accuracy of 100%. Superficial parotidectomy is the most common surgery performed for 
neoplastic lesions (56.4%). Wound infection is the most common post operative 
complications. 
CONCLUSION: 
 Non-inflammatory and neoplastic salivary swellings are common in the middle 
age group and in females. Non-inflammatory swellings are more common in 
submandibular salivary glands. Sialolithiasis predominated the non-inflammatory 
swellings. Neoplastic swellings are more common in parotid gland and pleomorphic 
adenoma dominates the neoplastic swellings. FNAC has got a good accuracy in 
diagnosing salivary gland tumours. Pain X ray has got accuracy in diagnosing 
sialolithiasis. Surgery is the main modality in the treatment in both non inflammatory and 
neoplastic salivary gland swellings. Early diagnosis of the condition with subsequent 
surgical management carries a very good prognosis. 
KEYWORDS: 
 Parotid gland; Submandibular gland; sublingual gland; pleomorphic adenoma; 
adenoid cystic carcinoma; superficial parotidectomy; excision of submandibular salivary 
glands. 
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INTRODUCTION 
Salivary glands are classified as  major and minor glands.They  comprise a complex 
anatomic and physiologic “organ” systems.They  produce enzyme  lubrication, mixing agent 
and immune factors. They are affected by host of pathologic conditions .They are infection, 
immune disorder, hypertrophy and atrophy, systemic diseases and “neoplasms. 
Salivary gland swellings can be broadly classified into inflammatory, non-
inflammatory and neoplastic swellings like calculi, benign tumours ( pleomorphic adenoma, 
oncocytoma, warthin's tumour) or malignant tumours (adenocarcinoma, adenoid cystic 
carcinoma and undifferentiated carcinoma) and  connective tissue diseases like 
haemangioma, lymphangioma, neurofibroma and other auto immune diseases like Sjogren's 
syndrome, Mikulicz disease etc. 
Acute inflammatory conditions generally can be diagnosed by history and physical 
examination alone, whereas chronic inflammatory diseases and granulomatous disorders 
require supplemental diagnostic information including lab tests, imaging studies and biopsy. 
Accurate pathological diagnosis is necessary for proper management of neoplastic disorders'. 
Most of primary epithelial tumours occur in parotid glands. 7- 11% in the 
submandibular glands are malignant.Less than 1% occur  in the sublingual glands.  9-23% 
occur  in the minor glands. 15-30% of tumours of  parotid gland are malignant.  40% in the 
submandibular gland are malignant. 50% in the minor salivary gland are malignant.  70-90% 
of sublingual glands are malignant. 
These salivary gland tumours usually occur in adults with a female predominance. 
Warthins tumour(WT) are more common in males 5'6.  
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FNAC of salivary gland tumours is helpful to both the patient and the clinician.  Its 
immediate results, accuracy, lack of complications and economy are favourable. Appropriate 
treatment management can be planned earlier, local excision for benign neoplasm or radical 
surgery for malignany. With non-neoplastic lesions, metastasis and lymph proliferative 
disorders, conservative management, chemotherapy or radiotherapy might be respectively 
preferable. 
In this dissertation an attempt has been made to present various conditions of the 
salivary gland swellings admitted in Govt.Royapettah hospital and kilpauk medical college 
hospital Chennai, from NOV 2014 to AUG 2015. All the cases are analysed and compared to 
the data available in literature. 
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OBJECTIVES OF THE STUDY 
1) To study the age and sex distribution among cases of salivary gland swellings. 
2) To study the mode of clinical presentation of various salivary gland swellings.  
3) To study the accuracy of FNAC in the diagnosis of salivary gland swellings  
4) To study the methods of current surgical treatment of salivary glands swellings.  
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REVIEW OF LITERATURE 
HISTORICAL ASPECT 
• History of salivary gland disease date backs to times of Hippocrates.  
• Earliest reports of parotid extirpative surgery were recorded in Dutch literature of late 
160010 . 
• Riolan (1648): First to recognize the glandular substance of parotid glands.  
• Lorenzo-Heister (1765): Described the earliest parotidectomy performed.  
• Early successful parotidectomies include a publication by Siebold in 1781, McClellan 
in 1824 and Lisfranc in 1826. 
• Heyfelder (1825) was able to avoid facial paralysis while performing parotidectomy.  
• According to Foote and Frazel, term mixed tumour dates from Minssen's review in 
1874- Which is cited by Ahlbom.A name change to pleomorphic adenoma was 
suggested in 194811 .  
• Use of RT for treatment of parotid mixed tumour was done by Kirmission in 1904.  
• Papillary cystadenoma lymphomatosum was described by Hildebrad in 1895, 
Nicholson in 1923 and  Warthin in 192912 . 
• In 1926, Schutz reported a case of basal cell adenoma. Kleinasser and Klein were the 
first to suggest using this term. 
• The oncocyte, which is derived from Greek word `onkoushthai' meaning swollen or 
enlarged, was initially described in 1897 by Schaffer, McFarland in 1927 and in 1931 
by Hamper12. 
• Schaffer drew the attention to the high recurrence associated with enucleation.   
• Nasse, in 1892 and  In 1953, Buxton and colleagues were to describe a malignant 
potential to many of acinic cell tumours12 . 
5 
 
• The preferred terminology for malignant pleomorphic adenoma is the carcinoma ex 
pleomorphic adenoma coined in 1970.  A 'surgical' superficial lobe could be dissected 
away from the 'surgical' deep lobe maintaining the continuity and integrity of facial 
nerve during the dissection (Furstenberg, McWhorter, Beahrs, Kidd H.A.) was found. 
• First Facial nerve preserving parotidectomy was performed by Carwardine in 190710 .  
• Superficial parotidectomy with conservation of facial nerve was suggested by Taylor 
and Garcelon in 1948.  
• Patey (1940) recognized that frequent recurrence after enucleation was the result of 
capsular defect 15 . 
• Bailey (1941): stressed importance of capsule and anatomy of VII cranial nerve in 
parotid gland.16 
• In 1942, Kaplan recommended RT for  parotid malignancy. 
• In 1942 Ledeman suggested the routine use of post op RT. 
• In 1943 R.M.James developed approach of identifying the facial nerve17 . 
• Nerve grafts using great auricular nerve was reported in 1945 by Furstenberg and 
Beahrs.18 
• Patey (1954) fully defined and described conservative radical parotidectomy.19 
• Karolinske (1960) popularized the use of FNAC in parotid tumours in Karolinska 
Institute of Stockholm. Cohen ET alin 1990 achieved an overall Accuracy of 88% for 
FNAC of salivary gland tumours. 
• Richard L. Fabian in 1994 reported that salivary neoplasms are encountered at all 
ages.21  
• Gorden T. Deans.et al in 1995 found that superficial parotidectomy is advised for 
superficial lobe involment 22 .  
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• McGraw M. and K.Husan in 1997 studied that FNAC can distinguish benign from 
malignant parotid disease in 93%. 23 . 
 
• Joseph Califano, et al in 1999 reported that approximately 80% salivary gland  
tumours are found in parotid remaining in others24 . 
• A two year study of clinic-pathology of primary salivary gland tumours conducted at 
SMHS hospital in Kashmir from AUG-1998 to AUG-2000 revealed, median age of 
benign tumours is 4th decade; malignant tumours are in 5th decade. Out of100 cases 
parotid was involved in 70percent of the cases with pleomorphic adenoma forming 
the largest group of tumour sites, FNAC diagnosis correlated with histopathological 
diagnosis in 98.4 percent of cases. 
• A 12 year study by a Turkish literature, conducted by department of pathologyand 
otorhinolaryngology, CUKUROVA University concerning FNAC, revealed that 
FNAC has 94% sensitivity and 100%specificity in diagnosing salivary gland 
conditions29 . 
• The major salivary gland lesions yield good ultrasound results because of  their 
location and  soft tissue characteristics. They are the initial imaging modality of 
choice for investigating focal salivary gland lesions and with good interpretation  
obviating  the need for CT/MRI30 . 
• In the Journal laryngoscope 2010 may, old trans cervical route submandibular 
excision was replaced by endoscopic hairline incision31 . 
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ANATOMY 
Definition:  
Salivary gland is a cell or organ. It discharges  secretion into  oral  cavity.  
Major salivary glands: 
They lie at a distance from oral mucosa. They communicate through one or more 
extra glandular duct. Comprise 3 pairs namely, 
- Parotid gland  
- Submandibular gland and 
- Sublingual gland . 
 Parotid gland is  largest (14 to 28gm). The submandibular gland  about 1/4th the Size of 
parotid (7-8gm) and the sublingual gland is about 1/3rd the size (3g) of Submandibular gland.  
Minor salivary glands:  
They lie in mucosa or sub mucosa and open directly or indirectly via many short 
excretory (collecting) ducts, on to the epithelial surface of the mucosa. They comprises 
anterior lingual gland, mucus membrane of tongue, small labial, buccal and palatal gland in 
relation to mucus membrane of the lips, cheek and roof of mouth respectively.  
Ectopic salivary glands:  
Present in any of the following sites i.e. eyelid, lacrimal gland, middle ear, PNS, nose, 
jaws, skin of the face and neck. 
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EMBRYOLOGY 
Salivary glands are derived from ectoderm layer of the oral cavity. There are 3 stages 
of development of salivary glands.  
1. Branching dichotomous ducts (solid epithelial bud) develop from the salivary 
anlagen.  
2. Duct acquires lumen and gland lobular form and continues through 7th embryonic 
month.  
3. Begins in 5th embryonic month, as differentiation of acini and maturation of gland, 
surrounding mesenchyma forms the capsule and interlobular septet for  parotid and 
submandibular gland.33 
• Parotid gland development, beginning in 6 week of intrauterine life. An elongated 
furrow running posteriorly from  angle of mouth between mandibular arch and 
maxillary process is formed. Groove is converted into a tube and it persists as a 
parotid duct and its blind end proliferates to form the gland. The interstitium in which 
parotid gland develop is rich in lymphoid tissue and this feature is almost totally 
absent in Submandibular and Sublingual glands. Sebaceous glands are rare  in  
parotid gland. The acinar cells occur from pre-existing acini and other cells of ductal 
origin. As the gland arborises posterior, the facial nerve migrates anteriorly through 
it.  
• Submandibular gland begins to develop in the 6 week of IUL. Unlike parotid, it 
develops as a relatively discrete structure with early condensation of its mesenchyma 
it develops as an epithelial outgrowth from the floor of the linguo-gingival groove. 
• Sublingual gland begins to develop in 8 week of IUL. 
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HISTOLOGY 
Both major, minor Salivary glands possess acinar and duct system. These glands may 
be of the serous, the mucous, or the mixed, sero-mucous type. The parotid and the vonebner's 
glands of the tongue are exclusively of serous make up. The palatal Salivary gland and those 
situated at  base and lateral border of  tongue are predominantly of  mucous type. The 
submandibular gland is mixed as it has both serous and mucous components, but 
predominantly serous; while Sublingual gland is also mixed but predominantly mucous.  
Saliva is formed by the acinar cells which contain well-developed endoplasmic 
reticulum and Golgi bodies with abundant secretary granules and unmyelinated nerve 
terminals with numerous synaptic vesicles just between the acinar cells indicating autonomic 
innervations.  
The myoepithelial cells (Zimmerman's cells), also referred to as basket cells, as they 
ensheath the individual acini. They appear to have the ability to contact and expel saliva from 
the acini. The myoepithelial cells play an important role in  transport and basement 
membrane function.  
HISTOLOGY OF THE DUCTAL SYSTEM 
The cells of the striated ducts are well differentiated and show features common to the 
renal proximal tubule cells. These cells play an important role in water and electrolyte 
transportation. The intricate duct system is composed of 3 distinct elements, namely, the 
intercalated, the striated, and the interlobular ducts. The most important function of these 
ducts is active saliva secretion. The terminal portion of the duct system is formed by 
intercalated ducts. Depending on the circumference of these ducts, multiple striated layers of 
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epithelial cells are present. Elastic and collagen fibres surround the periphery, facilitating the 
active transport of saliva through the system34.  
The intercalated ducts and acini represent the terminal position of the system (duct 
acinar unit) under normal conditions; the reserve cells of the intercalated ducts are the source 
of regeneration of the acinar tissue and the terminal duct system and are thought to be the 
progenitors of most salivary gland tumours. 
The lymphoid tissue of the region is represented by small nodes located near or within 
the parotid gland and by scattered lymphoid cells located in the connective tissue around the 
acini and ducts. The latter are thought to be a part of the MALT. 
SURGICAL ANATOMY 
PAROTID GLAND: 
(Para-otic means by the side of ear)It is the largest and has an average weight of 
25gms. It forms irregular, lobulated, yellowish mass,  below  external acoustic meatus and is 
wedged between mandible and  mastoid; it projects forward on  surface of the masseter. 
The parotid gland is like an inverted, flattened 3 sided pyramid, bases of which is the 
superior pole and tail/apex- inferior pole; 3 borders, namely, anterior, posterior and medial; 3 
surfaces namely, lateral, antero-medial and postero-medial. Although not found in every 
gland, 3 - 5 process of parotid gland exist, making it extremely difficult to perform a total 
parotidectomy.  
Three superficial processes: 
1) Condylar process near the TM joint,  
2) Meatal process in the medial area of the incisura of external auditory canal,  
3) Posterior process- projecting between the mastoid and S.C.M. muscle.  
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Two deep processes: 
1) Tympanic process rest on temporal bone. 
2) Stylomandibular process projects anteromedially above the stylomandibular ligament.  
Structure within parotid substance: These from without inwards are 
• Facial nerve and  branches,  
• Retromandibular vein and its tributaries (superficial temporal and maxillary veins) 
• External carotid artery and its branches (superficial temporal and maxillary arteries).  
• The retromandibular vein joins  posterior auricular vein to form  external jugular vein.  
• Facial nerve has 2 divisions namely tempero-facial and cervico- facial. A plane 
formed by joining the facial nerve and the retromandibular vein is called the facio- 
venous plane of patey. This plane divides the parotid into a superficial lobe (constitute 
4/5 of the gland bulk) and deep lobe.  
Parotid duct: 
It arises from  deep surface of  gland on its ventral  aspect. It  unites with the duct 
from the superficial lobe and accessory gland at  anterior border of  masseter . It runs an inch 
below zygoma and is 5cm long. At anteriorborder of masseter, it runs inwards to pierce 
successively the corpus adiposum , bucco pharyngeal fascia and the buccinators to open upon 
a small papilla in the vestibule of  mouth opposite  crown of upper second molar tooth32 . 
Surface marking: 
 Parotid gland is marked by lines connecting the following points successfully. 
1) A point on the mastoid tip.  
2) A point on the condyle of the mandible. 
3) A point on the middle of the masseter muscle.  
4) A point below and behind angle of the mandible. 
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The parotid duct Is marked by the mid third of a line joining the philtrum of the upper 
lip to the tragus of the ear.  
Histology: It shows 3 characteristics. 
1) Serous acini and few mucous acini  
2) Plenty of ducts,  
3) Fat in between these two.  
Blood Supply: 
• Arterial supply  from external carotid artery, 2 terminal branches. 
• Venous drainage is to retrornandibular and external jugular veins.  
• Lymphatic drainage: Parotid nodes and  upper deep cervical nodes.  
Nerve Supply: 
Parasympathetic nerve fibres are secreto-motor in nature and arrive to  gland through  
auriculotemporal nerve from  inferior salivary nucleus, present at the medulla. 
Sympathetic nerve fibres are vasomotor in nature and arise from the plexus on the 
external carotid artery with the superior cervical ganglion as the primary source of supply.  
Sensory supply is from the auriculotemporal nerve to the gland and the greater 
auricular nerve (C2) to the fascia. 
 Facial Nerve: It arises from 2 nuclei in the lower Pons, namely the main motor 
nucleus and the smaller nucleus giving rise to the nervus intermedius, which contains 
parasympathetic and sensory nerve fibres. The facial nerve enters the internal acoustic meatus 
and after variable course in the petrous temporal bone exits through the stylomastoid 
foramen. It  enters  parotid gland and divides into  2 main divisions, upper tempero facial and 
lower cervico facial. The 2 main divisions, in turn again divide into 5-6 terminal branches. 
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These form an appearance of a duck's feet and are called pesanserinus. The terminal branches 
are temporal, zygomatic, buccal, from the zygomatico-facial division and mandibular and 
cervical from the cervicofacial division.  
Applied Anatomy: 
1. The parotid gland is considered to be a `u' shaped structure . Patey's plane divides the 
gland into 2 lobes arbitrarily, and forms a convenient level for dissecting out tumours 
confined to the superficial part.  
2. Malignant tumours of the gland infiltrate and invade the facial nerve, causing partial 
or total paresis. 
3. The preauricular lymph nodes are superficial to the parotid capsule and constant in 
location viz., anterior to the tragus. But parotid nodes are deeper to the capsule and 
can be found in 3 location viz., on  surface of  gland, within the parenchyma of  gland 
and deeper to  gland between it and the lateral wall of the pharynx. It is important to 
remove all nodes in total parotidectomy. 
SUBMANDIBULAR SALIVARY GLAND 
It is the 2nd largest salivary gland, situated in digastrics triangle. It is about size of 
walnut, horizontally placed ‘U’ shaped, with the limb of U wrapping posterior free edge of 
mylohyoid muscle. Upper limb of U is deep to mylohyoid (deep lobe). Lower limb is 
superficial to mylohyoid (superficial lobe). 
Facial covering: 
The investing layer of deep cervical fascia splits as 2 leaves to enclose the superficial 
lobe. 
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Relations: 
The superficial lobe has 3 surfaces 
1) Inferior surface. 
2) Lateral surface.  
3) Medial surface.  
Submandibular Duct: 
It is 5cm long and 3mm wide. It begins as numerous branches in superficial region 
and runs through  deep lobe passes upwards and  backwards  4-5 mm and then turns forward 
to run between mylohyoid and the hyoglossus. It opens into sublingual papilla through an 
ostium, one on either side of fraenulum of the tongue.  
Blood Supply: 
• Arterial supply is from facial artery and a few twigs of the lingual artery. 
• Venous drainage is to common facial and lingual veins. 
• Lymphatic drainage is to submandibular and upper deep cervical nodes.  
Nerve Supply: 
• Parasympathetic nerve fibres (secretomotor) come through the lingual nerve and its 
chorda tympani branch from the superior salivary nucleus in the lower Pons in the 
brain.  
• Sympathetic nerve fibres (vasomotor) arrive to  gland from  plexus on  facial artery,  
primary source of supply being the superior cervical ganglion.  
Histology: It has serous and mucinous acini in equal in number and few ducts.  
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Applied Aspects: 
1. Submandibular gland is related to 2 nerves on superficial aspect (marginal mandibular 
and cervical divisions of facial nerve) and 2 nerves on its deeper aspect (lingual and 
hypoglossal). These should be protected during surgery. 
2. Submandibular gland is palpable bi digitally only when the whole gland is enlarged.  
SUBLINGUAL GLAND 
 Sublingual gland is  smallest of  paired salivary glands. It weighs 3-4 gm each and is 
narrow, flattened and almond shaped.  
• Ducts: 8-20 in number and open directly and separately into floor of  mouth near 
summit of sublingual fold or indirectly into the submandibular duct. These ducts are 
called the ducts of Rivinus.  
Blood supply:  
• Arterial supply  from facial and lingual arteries. 
• Venous drainage through  lingual veins.  
• Lymphatic drainage is to submandibular lymph nodes.  
Nerve supply: 
Parasympathetic fibres are secretomotor and arrive from superior salivary nucleus. 
Sympathetic is from same source as submandibular gland.  
• Histology: It has purely mucinous acini and plenty of ducts. 
ANATOMY OF MINOR SALIVARY GLANDS  
Minor salivary glands  are located in  the submucosa of  oral cavity.  
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• The anatomic distribution of minor salivary glands show that hard and soft palate are 
the most common anatomic sites, followed by maxillary sinus, upper lip mucosa, oral 
mucoosa of the cheek area, gigiva, nasopharynx and pharynx, tongue, lower lip 
mucosa and larynx  
• More  in posterior hard palate 
-  salivary unit with own simple duct 
- Most  minor salivary glands are mucinous with  main exception of Ebner's 
glands which are serous glands located in  circumvallate papillae of  tongue. 
•  Minor salivary glands are important in oral cavity and their secretions directly bathe 
the tissues. Individual glands are in  submucosa between muscle fibres, and consist of 
groups of secretory endpieces made of mucous acinar cells and serous or seromucous 
demilune cells112 .  
PHYSIOLOGY 
The total salivary secretion is 1 to 1.5 litres per day with a pH between 7.0 - 8.0.  
 ACTIONS OF SALIVA:  
1. Moistens dry foods to aid swallow.  
2. Provides  medium for dissolved  food materials  chemically stimulating taste Buds.  
3. Buffering of the contents of oral cavity through its high HCO3 ions concentration. 
4. Digestion by amylase. 
Control of Salivary Secretion:  
Parasympathetic nerve stimulation causes, profuse watery secretion and sympathetic 
nerve stimulation causes thick scanty secretions. There are phases of secretion, namely  
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• Cephalic phase: In which smell sight and the thought of the food causes 
salivation; 
• Oral phase:  in which when food enters the mouth the salivation is induced.  
• Gastric phase: In which food entering the stomach causes salivary secretion. 
Salivary gland controlled mainly by PNS from  salivary nuclei.  
Salivary secretion is also controlled by CNS. The appropriate areas in  brain are 
located near parasympathetic centres of anterior hypothalamus,  from  taste and smell areas of  
cerebral cortex or amygdala. Salivation occurs by  reflexes originating in  stomach and upper 
intestine.  
Salivary Gland Histology Nature of Secretion 
Quantity of 
Secretion (%) 
Parotid Serous Watery 20 
Submandibular Seromucinous Moderately Viscous 70 
Sublingual Mucinous Viscous 5 
 
Sympathetic nerves arise from  superior cervical ganglia.They  travel along 
blood vessel to  salivary gland11,37.  
BIOCHEMISTRY 
The specific gravity of saliva varies from 1.002 to 1.012. Viscosities of the 3 major 
Salivary glands are Parotid-1.5, Submandibular-3.4 and Sublingual-13.4centipoises.  
Majority of total volume of saliva comes from parotid and submandibular glands. Sublingual 
glands contribute 3%37.  
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Composition of Saliva: 
Substance Mean Value Parotid Submandibular 
Flow rate 
(ml/min/gland; stimulated) 
Inorganic analytes (meq/l) 
0.7 0.6 
K+ 
Na++ 
Cl- 
HCO3 
Ca++ 
Mg++ 
HPO42-(mg/dl) 
20 
23 
23 
20 
2 
0.2 
6 
17 
21 
20 
18 
3.6 
0.3 
4.5 
Organic analytes (mg/dl)   
Urea 15 7 
Protein 250 150 
Substance Mean Value Parotid Submandibular 
Ammonia 0.3 0.2 
Uric acid 3 2 
Lysozymes 2.3 105 
Glucose <1 <1 
IgA 4 2.0 
Amylase 
Cholesterol 
pH 
fatty acids 
total lipids 
amino acids 
0.1 
<1 
5.92 
1 
12-6 
1.5 
0.002 
- 
5.73 
- 
2-6 
- 
 
CLASSIFICATION 
Salivary gland disorders can be broadly classified as  
• Acute Inflammatory Lesions  
- Mumps  
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- Acute Suppurative Sialadenitis 
• Chronic Inflammatory Disorders  
• Granulomatous Diseases 
- Primary Tuberculosis of the Salivary Glands  
- Animal Scratch Disease  
- Sarcoidosis  
- Sjogren's Syndrome 
- Sialolithiasis  
• Cystic Lesions  
• Radiation Injury  
• Trauma  
• Sialadenosis  
• Other Disorders  
• Neoplastic Disorders  
- Benign  
- Malignant  
“WHO CLINICAL CLASSIFICATION OF SALIVARY GLAND TUMOURS”  
(1991)38  
I. “Adenomas”  
1) Pleomorphic adenoma  
2) Warthin's tumour  
II. “Carcinomas”  
1) Acinic cell carcinoma  
20 
 
2) Mucoepidermoid carcinoma  
3) Adenoid cystic carcinoma  
4) Adenicarcinoma  
5) Squamous cell carcinoma  
6) Undifferentiated carcinoma  
7) Carcinoma in pleomorphic adenoma  
III. Non-Epithelial Tumours  
1) Haemangioma  
2) Lymphangioma  
3) Neurofibroma  
4) Neurilemoma  
IV. Malignant Lyphoma  
V. Unclassified and Allied Conditions  
ETIOLOGY OF SALIVARY GLAND SWELLINGS 
Salivary gland is  affected by  various disorders39.  
1. Acute Bacterial and Viral Infection of Salivary Glands  
Bacterial infection: It plays a most important role in the etio-pathogenesis of salivary 
gland swellings. Bacterial infections of the salivary gland swellings results from two 
important physiological mechanism.  
• Retrograde contamination of salivary ducts and parenchyma tissues by 
bacteria inhabitating oral cavity  
• Stasis of  salivary flow through  ducts. 
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2. Chronic Sialadenitis  
Chronic sialadenitis is  due to decreased secretion rate and  salivary stasis, like 
acute sialadenitis it is more common in parotid gland and usually occurs from 
permanent damage to the gland from acute suppurative infection41.  
3. Sialolithiasis: 
Sialolithiasis is one of the most common causes of salivary gland swellings.  
Origin of calculi lies in relative stagnation of  calcium rich saliva42.  
4. Sialadenosis  
Sialadenosis is non-inflammatory, non-neoplastic enlargement of salivary 
gland, usually  parotid. Bilateral parotid gland swelling is common in obesity43.  
5. Mucoceles:  
   These are pseudocyst with extravasatory mucus . Common in sub lingual and sub 
mandibular glands. 
These lesions are divided into 2 types, oral ranulas, cervical or plunging ranula. 
Pathophysiology of Mucus Retention Cyst  
• The development depends on disruption of  flow of saliva from  secretory 
apparatus of  salivary glands 
• Accidental injury.  
6. Salivary Gland Tumours  
Many factors have been implicated in the cause of the salivary gland tumours.  
• Viruses: The Epstein- bar virus, polyoma virus, CMV and human papilloma virus 
types 16 and 182. 
• Radiation:  
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a) Japanese people, who were exposed to radiation generated by the atomic bombs 
dropped on Hiroshima and Nagasaki, have demonstrated increased risk for 
developments of salivary gland tumours.  
b) The tumorogenic effects of therapeutic radiation to the head and neck on salivary 
gland tissue have been assessed in Michael Reese hospital in Chicago.  
• Occupation:  Asbestos mining, manufacturing of Rubber products and industries such 
as Shoe manufacturing, Plumbing and Wood working in the Automobile industries45. 
• Hormones:  Salivary gland tumours in woman have increased  estrogens receptor 
levels and also prolactin binding activity45 . 
Histogenesis of Salivary Gland Neoplasms 47 
• Multicellular THEORY. 
 
Oncocytic Tumours derived from Striated duet cells 
Acinous Tumours derived from Acinar cells 
Squamous cell carcinoma derived from Excretory duct cells 
Mucoepidermoid 
Carcinoma 
derived from Excretory duct cells 
Mixed Tumours derived from 
Intercalated duct cells and 
Myoepithelial cells 
 
• Bicellular Theory 
 
Intercalated duct reserve cells 
• Pleomorphic adnoma 
• Warthin’s tumor 
• Oncocytoma 
• Acinous cell tumors 
 
Excretory duct reserve cells 
• Squamous cell carcinoma 
• Mucoepidermoid carcinoma 
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PATHOLOGY 
 A salivary gland tumour, by its complex histological appearance, makes interpretation 
Difficult. One of the pre-requisites for comparative studies is agreement on criteria for 
classification of tumours and a standardized nomenclature.  
Classification by Foote and Franzell 1954 
Benign Malignant 
1. Papillary Cystadenoma 
lymphomatosum 
1. Malignant mixed tumor 
2. Oxyphil adenoma low grade 
and high grade 
2. Mucoepidermoid tumor, low grade 
and high grade 
3. Sebaceous cell Adenom 3. Squamous cell Carcinoma 
4. Benign Lymphoepithelial 
lesion 
4. Adenocarcinoma 
5. Unclassified 
5. Adenoid cystic Carcinoma 
6. Trabacular or solid Carcinoma 
7. Anaplastic Carcinoma 
8. Mucous cell Carcinoma 
9. Pseudo adamantine Carcinoma 
10. Acinic cell Carcinoma 
 
Revised WHO Histological Classification (Siefort & Sobin 1992) 
1. “Adenomas”  
1.1 Pleomorphic adenoma  
1.2 Myoepithelioma (Myoepithelial adenoma)  
1.3 Basal cell adenoma  
1.4 Warthin tumor (adenolymphoma)  
1.5 Oncocytoma (oncocytic adenoma)  
1.6 Canalicular adenoma  
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1.7 Sebaceous adenoma  
1.8 Ductal papilloma  
1.8.1 Inverted ductal papilloma  
1.8.2 Intraductal papilloma  
1.8.3 Sialadenoma papilliferum  
1.9 cystadenoma  
1.9.1 Papillary cystadenoma  
1.9.2 Mucinous cystadenoma  
2. Carcinomas  
2.1 Acinic cell carcinoma  
2.2 Mucoepidermoid carcinoma  
2.3 Adenoid cystic carcinoma  
2.4 Polymorphous low grade adenocarcinoma  
2.5. Epithelial- myoepithelial carcinoma 
2.6 Basal cell carcinoma  
2.7 Sebaceous carcinoma  
2.8 Papillary cystadenocarcinoma  
2.9 Mucinous adenocarcinoma  
2.10 Oncocytic carcinoma  
2.11 Salivary duct carcinoma  
2.12  “Adenocarcinoma”  (nos)  
2.13 Malignant myoepithelioma (myoepithelial carcinoma)  
2.14  “Carcinoma in pleomorphic adenoma” 
2.15  “Squamous cell carcinoma” 
2.16  Small cell carcinoma 
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2.17  Undifferentiated carcinoma 
2.18 Other carcinoma  
3. Nonepithelial tumors  
4. Malignant lymphomas  
5. Secondary tumors  
6. Unclassified tumors  
7. Tumor like condition  
7.1 Sialadenosis  
7.2 Oncocytosis  
7.3 Necrotizing sialometaplasia (salivary gland infarction)  
7.4 Benign lymphoepithelial lesions  
7.5 Salivary gland cyst  
7.6 Chronic sclerosing sialadenitis of submandibular gland (kuttner tumor)  
1.7 Cystic lymphoid hyperplasia in AIDS.  
1) Pleomorphic adenoma (PA): 
Morphology: 
The tumour is typically well circumscribed, thinly encapsulated and solitary, smooth 
or lobulated. C/S shows greyish white areas rubbery, fleshy, mucoid or glistening, depending 
on the content and amount of the stroma, with translucent bluish areas which represent 
cartilage with a myxoid stroma may have slimy consistency11.  
Microscopy: 
Growth Pattern: It shows pseudo encapsulation, which sends extensions or 
pseudopodia, called satillosis. Hence, simple enucleation is associated with high rate of 
recurrence. For this reason, mixed tumour was thought to be a low grade malignancy, earlier. 
Occasionally tumour islands may appear outside the capsule.  
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Basic cellular organization: 
 There is an epithelial component and a stromal component, and both can be 
remarkably pleomorphic. The epithelial component consists of epithelial and myoepithelial 
cells. Epithelial component  may be arranged in anastomosing tubules, small cysts, ribbons 
and solid sheets.  
Stroma:  
Extracellular stroma is one of the defining components of PA. The stroma takes the 
form of a mixture of chondroid (hyaline cartilage), myxoid, chondromyxoid, hyaline. 
Tyrosine and oxalate crystals can develop and are unique to PA11. 
2) Warthin's tumour (Adenolymphoma/Papillary cystadenoma lymphomatosum):  
Morphology: The tumour is well encapsulated with thin tough capsule which is usually 
intact, fluctuant to firm rubbery in consistency. C/S is solid or papillary reddish grey and 
shows multiple cysts few mm to cm which is nearly pathognomonic, its fluid is serous/ 
mucoid/ chocolate or semisolid caseous material.  
Microscopy: Irregular cystic structures in which the lining epithelium is thrown into papillary 
folds.  A distinct layer of basement membrane separates the papillae or cystic lining from the 
lymphoid stroma. The lymphoid stroma consists of small lymphocytes, plasma cells, 
histiocytes, germinal centre and sinusoids. Combination of lymphoid matrix and papillation 
of eosinophilic epithelial cells forming cystic spaces presents a distinct and pathognomonic 
histological feature. 4 subtypes are recognized by Siefert:  
• Subtype 1 (classic WT) is 50% epithelial,  
• Subtype 2 (stroma poor) is 70-80% epithelial,  
• Subtype 3 (stroma rich) is only 20-30% epithelial and  
• Subtype 4 is characterized by extensive squamous metaplasia51. 
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3) Monomorphic adenoma:  
Characteristic feature is monomorphic cellular composition, probable origin from the 
intercalated duct reserve cell. They manifest as purely epithelial or purely  mesenchymal 
growth pattern.  
a) “Basal cell adenoma”:  most common monomorphic adenoma and likely represents the 
isocellular counterpart of PA.  
Morphology: Well encapsulated, well circumscribed. C/S is uniform and varies from 
light tan to brown, homogenous. Surface is usually multifaceted and multinodular.  
Microscopy: Small basaloid cells possessing round, uniform, basophilic nuclei and scant 
cytoplasm. Nuclear pleomorphism and mitosis are not seen. There are 4 morphological 
patterns. 
1. Solid type: most common pattern. Basaloid cells form broad bands, smooth  
contoured islands and solid masses with peripheral palisading which can be so 
prominent as to mimic Ameloblastoma.  
2. Tubular Type: Least common type, in which discrete or anastomosing tubules 
predominate. The tubules are lined by two distinct layers of cells, with inner cuboidal 
ductal cell.  
3. Trabacular Type: This type consists of narrow and broad trabeculae of cells 
interconnected with one another, producing a reticular pattern. 
4. Membranous Type: This differs from other subtypes by the presence of abundant, 
thick, eosinophilic and PAS +, hyaline basal lamina material around the smooth 
contoured tumour islands.  
a) Myoepithelioma:  
Morphology: Well circumscribed, frequently well encapsulated.  
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Microscopy: This type of adenoma consists entirely of myoepithelial cells. The different type 
described are, the spindle and stellate myoepithelioma, clear cell variant and a malignant. 
Tumours have scanty intervening hyalinised stroma.  
Three morphological patterns  
1. Spindle cell- most common especially in parotid.  
2. Plasmocytoid- commonly seen in palatal tumours.  
3. Epitheloid/clear cell- Stroma contains chondroid material 52.  
a) Oncocytoma (oxyphil adenoma):  
Morphology: Well circumscribed and thinly encapsulated. External surface of the tumour is 
smooth. The C/S is mahogany brown, solid with focal areas of red brown haemorrhage.  
Microscopy: Hallmark of this is presence of oncocyte, polygonal cells possessing abundant 
eosinophilic granular cytoplasm as it contains large number of mitochondria, central round 
nuclei and often-distinct nucleoli, arranged in solid sheets or in nests and cords, which form 
alveolar or organoid patterns, which are separated by thin fibrous septa or scanty loose 
vascularised stroma53, 54.  
 
a) Canalicular Adenoma:  
It is an uncommon benign salivary gland tumour  in  intra oral glands. The average 
age for canalicular adenoma is 65 y. The female to male ration is 1.7 to 1. Most commonly in 
upper lip and buccal mucosa.  
Gross: The gross appearance  varies from encapsulated nodule to circumscribed, but 
unencapsulated. The size is about 1.7 cm in diameter. The colour has been reported to range 
from pink to tan or brown or yellow. Cut surface shows cystic spaces with gelatinous mucoid 
material.  
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Microscopy:  The cells are uniformly cuboidal or columnar. They usually have scanty 
eosinophilic cytoplasm with indistinct borders and the nuclear chromatin is diffuse and 
granular. The cells  produce long “canals”. Typically, the rows are separated periodically 
producing ductal structures. The stroma is delicate, richly vascular and sparsely cellular.64  
5. Sebaceous Adenoma : 
It is a rare tumour and accounts for 0.1% of all salivary gland neoplasm. There is a 
male preponderance and parotid glands are commonly involved. This is the only type of 
sebaceous neoplasm included in the WHO classification. 
Gross: it is encapsulated or  circumscribed, varies in colour from gray white to pinkish white. 
Microscopy: These tumours have sebaceous cell nests with minimal atypia and 
pleomorphism. Many tumours are micro cystic or  ectatatic salivary ducts with focal 
sebaceous differentiation. Sebaceous glands are  embedded in fibrous stroma65 . 
6. Ductal Papilloma: 
Seifert and colleagues apparently included sialadenoma papiliferum, intraductal 
papilloma and inverted ductal papilloma with a broad category of monomorphic adenoma 
that they called ductal papilloma or adenoma  
I. Intraductal Papilloma: 
Intraductal papillomas of salivary glands are rare. Male to female ratio is equal. Minor 
salivary glands are the most common site.  
Gross: The tumour is  well circumscribed cyst with  lumen filled with a friable tissue. 
Microscopy: It  arise in the duct system. This is unicystic and  composed of papillary fronds. 
The projections have delicate fibro vascular cores . Mucous cells may be interspersed among 
the ductal cells. 
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II. Sialadenoma Papilliferum: 
It  constitutes  0.1% of epithelial salivary  and 0.6% of benign epithelial tumours of 
minor salivary glands. Most common site is minor salivary glands.  
 
Gross: It is a round or oval, well circumscribed lesion. The lesions may be broad based or 
pedunculated. The surface of the tumour appears rough, pebbly, verrucous or overtly 
papillary. The lesion is often reddish. Cut sections reveal cauliflower like surfaces and 
circumscribed nodules of the tumour tissue that extend below the level of the mucosa.  
Microscopy: It  has exophytic and endophytic components. 
III. Inverted Ductal Papilloma:  
It is a rare tumour and occurs in adults. Minor salivary glands are  most common in 
lower lip and buccal mucosa.  
Gross: Inverted ductal papilloma occurs within the terminal portion of minor salivary gland 
excretory duct and therefore resembles a sialadenoma papilliferum. 
Microscopy: The microscopic features are different from sialadenoma papilleferum. It 
produces a bulging growth but it does not extend above the surface mucosa like the papillary 
fronds of sialadenoma papilliferum. Well circumscribed mass of basaloid and squamous cells 
are arranged in papillary configuration into luminal cavity. They appear to fill the cavity and 
extend outwardly into the surrounding lamina propria of the oral mucosa. The ductal lumen 
from which the inverted papilloma arises may communicate with the surface through an 
opening. It is covered by cuboidal duct cells and occasionally scattered mucosal cells.66.67 
7. Cystadenoma: 
These tumours constitute 2.2% of all benign epithelial tumours. These are most 
common after the 8th decade of life. Major salivary glands are involved in 65% of the cases 
and minor glands in 35% of the cases.  
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Gross:  Slowly enlarging swelling,  minor salivary gland tumours produce smooth nodule 
that may be compressible. Often the swelling represents a mucocele.  
Microscopy: Diagnostic histology criteria of cystadenoma are debated. The tumour is 
multicystic, well defined and may be encapsulated. The epithelial lining of the cysts can be 
cuboidal, flat or columnar. Oncocytic, as well as mucous changes of the lining may exist and 
occasionally are dominant.65 
MALIGNANT NEOPLASM  
1) Acinic cell carcinoma  
Morphology: It is often circumscribed with an incomplete capsule. The C/S is solid, with or 
without cystic areas. It is the most common parotid tumour to present as a cystic mass. The 
cyst may comprise only a small portion of the tumour or may be large with only small solid 
or papillary foci.  
Microscopy: They typically form a solitary mass or multiple nodules and invade in broad 
fronts. There can be variably prominent lymphoid aggregates, with or without lymphoid 
follicle formation. The neoplastic elements recapitulate the appearance of the acinar-
intercalated duct unit. Cells are arranged most commonly in organoid sheets traversed by 
ramifying delicate blood vessels.  3 histological patterns are recognized.  
a) Microcystic pattern: This is the most common pattern with multiple small empty 
spaces (micro cysts) producing lacy appearance. The neoplastic acinar cells 
possess basophilic granular cytoplasm and basally located nuclei. 
b)  Papillary cystic variant: This is characterized by large cystic spaces  with 
papillary projections. Hobnail cells, intercalated duct like cells, vacuolated cells 
and non-specific glandular cells cover the papillae. 
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c) Follicular variant: It comprises multiple, round cystic spaces filled with 
homogenous eosinophilic colloid material, highly reminiscent of thyroid 
follicles55. 
2) Adenoid Cystic Carcinoma (Cylindromatous carcinoma)  
Morphology: C/S shows tan, fleshy, firm invasive tumour.  
Microscopy: Infiltrative growth is usually obvious and perineural invasion is very common. 
There is no melting of basaloid cells in the stroma. The stroma is fibrous with variable 
amounts of myxo-hyaline material. 3 histological patterns are recognized  
a) Cribriform pattern: This is the most characteristic feature giving rise to a sieve 
like “Swiss Cheese” pattern. They are variable sized, smooth contoured, discrete 
to coalescent islands, comprising small, uniform basaloid cells punctuated by 
round sized spaces. Nuclear pleomorphism is usually mild and mitotic figures are 
usually few or absent.  
b) Tubular pattern: A single layer of ductal epithelial cells with a single or multiple 
layers of basaloid cells line the elongated tubules.  
c) Solid pattern: Smooth contoured or focally jagged sheets of closely packed 
basaloid cells characterize this type. These cells exhibit more significant nuclear 
pleomorphism and mitotic figures. The solid growth pattern is rarely present and 
if so, may not be recognizable as ACC. 
3) Mucoepidermoid Carcinoma  
Gross: They have ill-defined mass, which may be partially encapsulated.  
Microscopy: It comprises haphazardly dispersed mucin filled cysts, irregular tumour nests 
composed of mucous, squamous (epidermoid) and nondescript intermediate cells. Although 
the tumour borders can be circumscribed, most cases exhibit irregular invasive border at least 
focally. 
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 Low grade MEC: Mucin filled cystic structures constitute large proportions of the 
tumour and there are abundant mucous cells. Cells have bland nuclei and mitosis 
rarely seen. The intracellular mucin can be demonstrated readily by mucicarmine 
or diastase-PAS stain 
 High grade MEC: Contains more solid areas and few cystic spaces, perineural and 
intravascular invasion are common. The solid areas are formed by large polygonal 
squamoid cells with pale to eosinophilic cytoplasm and distinct cell borders, as 
well as intermediate cells.  
 Intermediate Grade: The intermediate grade tumour is histological between low 
and high-grade tumours. Some degrees of nuclear pleomorphism are observed in 
the tumour cells. Cystic spaces do not constitute a significant portion of the 
tumour.  
Variants: Pan Sclerosing variant shows keloid like sclerosis and peripheral lymphoid 
response 57. 
4) Adenocarcinoma 
Gross: Poorly circumscribed with irregular infiltrative borders. The C/S is tan and solid, with 
areas of haemorrhage or necrosis.  
Microscopy: Resembles gastro-intestinal carcinoma with mucin production and even signet 
ring cells. Tumours are characterized by glandular or ductal structures with variable 
organization. The glandular structures are composed of nondescript cuboidal cells58 . 
5) Malignant mixed tumours - Includes:  
a. A neoplasm with the basic pattern of mixed tumours, but in which all the epithelial 
elements are malignant.  
b. A true carcino-sarcoma where in both a carcinoma and recognizable mesenchymal 
malignancy co-exists.  
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Gross: Tumour may be obviously invasive or may grossly resemble a circumscribed benign 
mixed tumour. Necrosis, haemorrhage and cyst formation is common.  
Microscopy: There is histological evidence of destructive and infiltrative growth of a 
malignant neoplasm and there is pre-existing neoplasm with the features of a benign mixed 
tumour. The malignant component may be characteristic of adeno-carcinoma, squamous cell 
carcinoma or undifferentiated carcinoma54.  
6) Epithelial-Myoepithelial Carcinoma:  
• They are more common tumour of low-grade malignancy mainly seen in the parotid 
gland. The cells form ball-like or trabecular clusters and are both basaloid with 
scanty cytoplasm and myoepithelial with abundant pale, vacuolated cytoplasm. 
Nuclei are mildly atypical with a pale chromatin and discrete central nucleoli. 
Hyaline stromal material is present60.  
7) “Basal Cell Adenocarcinoma”: 
This accounts for 1% of malignant epithelial tumours of salivary glands. These 
tumours occur in adults. There is equal sex distribution for these tumours. Parotid gland is the 
most common site.  
Gross: These tumours are firm  and cut surface, shows uniform tan to gray white surface, 
often with a coarse and fine nodularity.  
Microscopy: The tumour is composed of various sized nests of cords of cells, a histological 
appearance similar to that of basal cell adenoma. However, unlike basal cell adenoma, the 
tumour grows in an infiltrative, destructive fashion. Necrosis and an increased mitotic rate are 
also seen in some cases. Perineural and intravascular invasion may be seen.  
8) Sabaceous Carcinoma: 
These tumours composed of  nests or sheets of sebaceous cells. The cells show 
different degree of maturity, pleomorphism, nuclear atypia and invasiveness. Cellular 
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pleomorphism and cytological atypia are uniformly present. The tumour cells have 
hyperchromatic nuclei and are surrounded by abundant clear to eosinophilic cytoplasm.61  
9) Papillary Cystadenocarcinoma  
These are rare tumours; the commonest sites of involvement are major salivary 
glands. Males and females are equally affected.  
Gross: These tumours are usually encapsulated, but may range from being encapsulated to 
being invasive. Cut surface, shows cystic areas. Lesions may be unicystic or multicystic, 
which range in size from 0.4 to 6cm.  
Microscopy: Tumour is composed of large cystic spaces lined by epithelium that often 
exhibit a papillary growth pattern. The cells lining the cystic spaces vary from tall columnar 
to cuboidal to simple squamous and may be mucous secreting.  
10) Oncocytic Carcinoma: 
This neoplasm is one of the least common of all the salivary gland malignancies. 
There is a male predilection for these tumours.  
Gross: Tumour size ranges from 0.5 to 8 cm with infiltration into surrounding structures.  
Microscopy:  These are arranged in an alveolar or synctial pattern and sheets or in cords. 
There is a much greater degree of nuclear and cellular pleomorphism and the number of 
mitotic figures is greater than that found in benign oncocytoma. Non encapsulation and 
vascular or neural invasion or both may be noted.61,67 
11) Salivary Duct Carcinoma:  
The incidence of salivary duct carcinoma is difficult to assess because most of the 
published surveys of salivary gland tumours do not include this specific category of tumour. 
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These neoplasms have a predilection for older males. The parotid gland is the commonest 
site.  
Gross: These tumours vary in size from less than 1 cm to greater than 6 cm in diameter and 
are usually yellowish grey to gray white. Sometimes they are multinodular but these tumours 
are usually infiltrative and poorly circumscribed.  
Microscopy: histological features show resemblance to that of ductal carcinoma of the breast. 
It is composed of atypical cells usually containing abundant eosinophilic cytoplasm that form 
back to back glands and often exhibit cribrifom, papillary or solid patterns.61 
12) Adenocarcinoma, Not Otherwise Specified (NOS): 
It affects patients primarily in the 4thto 8thdecade of life. There is a male predilection.  
Parotid gland is the most common site.  
Gross: A firm to hard mass replaces glandular parenchyma and compresses surrounding 
tissue.  Tumour invasion into the muscle and bone may be recognised. Cut surface is white or 
yellowish white and may reveal focal areas of haemorrhage and necrosis.  
Microscopy: The histological diagnosis of adenocarcinoma, NOS depends more on the 
exclusion of other characteristic types of salivary carcinomas than on the recognition of 
histomorphological features that are specific to adenocarcinoma, NOS.  
The common pattern in adenocarcinoma, NOS is glandular or duct like structures. The 
tumours may range from low to high grade.70 
13) Malignant Pleomorphic Adenoma: 
Salivary origin and relatively uncommon.  
Malignant pleomorphic adenomas include three  clinical and pathological entities.  
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a) Carcinoma Ex pleomorphic adenoma (carcinoma arising in a pleomorphic adenoma)  
b) Carcinosarcoma (true malignant pleomorphic adenoma)  
c) Metastasizing pleomorphic adenoma  
The first accounts for most of the malignant pleomorphic adenomas and second and third 
are extremely rare. These tumours constitute  12% of malignant salivary gland tumours and 
3.6% of all salivary gland neoplasms.72,73 
a) Carcinoma Ex Pleomorphic Adenoma:  
These tumours accounts for 95% of all malignant pleomorphic adenomas and 6.5% of 
all malignant tumours. They occur in the 6th to 8th decade of life with the mean age  56 
years. These tumours are common in females.  
Gross:   Poorly circumscribed and  extensively infiltrative. Occasionally, they may be 
encapsulated or well circumscribed. Cut-surface shows white or tan-gray colour and are hard 
in consistency. 
Microscopy : Most of the tumours are composed of typical benign pleomorphic adenoma 
with only small foci of carcinomatous tissue. Malignant areas  consist of epithelial cells with  
increased nuclear cytoplasm ratio, prominent nucleoli and  mitotic figures. The most common 
histological patterns in these areas are poorly differentiated adenocarcinoma or 
undifferentiated carcinoma. Destructive infiltrative growth is the most reliable histological 
criterion for the diagnosis. 
b) Carcinosarcoma: 
This is also called true malignant pleomorphic adenoma. It is a tumour in which both  
stromal and epithelial components fulfil histological criteria of malignancy. 
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Gross : The majority of carcinomas the grossly infiltrative with poorly defined margins. 
Occasionally, tumours are partially or totally encapsulated. Tumours range in size from 2 to 9 
cms in greastest dimension. Cut surfaces are usually grayish in colour and occasionally areas 
show cystic change, haemorrhage and calcification. 
Microscopy : Each of these tumours is biphasic, with varying proportions and types of 
sarcomatous and carcinomatous elements. Sarcoma is the dominant tissue in the majority of 
tumours with chondrosarcoma being the commonest. Tumours maymanifest areas of osteo 
sarcoma, fibro sarcoma, high grade sarcoma and malignant fibrous histiocytoma. 
c) Metastasizing Plemorphic Adenoma: 
It is common of the three types and here both the primary salivary gland tumour and 
its metastatic lesions are composed of typical benign appearing pleomorphic adenoma. 
Earlier literature has referred to these tumours as “benign metastasizing mixed tumours”67,70 
14) Squamous Cell Carcinoma: 
In one of the first comprehensive review of tumours of salivary glands in 1953, Foote 
and Frazell reported 39 primary squamous cell carcinomas. 
Squamous cel carcinoma represents 1.6% of all primary epithelial salivary gland 
tumours.  Most cases occur between 7 to 65 years. 
 There is a 2 to 1 male predilection. It accounts for 6.3% of parotid, 8.3% of 
submandibular and 3% sublingual epithelial malignancies. 
Gross : these tumours are unencapsulated, poorly demarcated and firm to hard in consistency. 
Cut surface is light gray or white. 
Microscopy : These tumours are similar to squamous cell carcinoma from other sites, ranging 
from low grade, highly keratinized neoplasm to poorly differentiated sheets of tumour cells 
with minimal keratinisations. Adjacent soft tissue invasion and regional metastasis are 
common. Trabaculae of desmoplastic fibrous connective tissue often separate the tumour into 
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multiple nodules. Islands of squamous cell carcinoma occasionally have marked infiltrates of 
lymphoid tissue in close apposition.59, 67. 
15) Small Cell Carcinoma 
These are extremely rare and account for less than 1% of major salivary gland 
tumours and account for 2.8% of minor salivary gland tumours. They are common between 
5th and 7th decade of life. There is a male predominance. 85% of the small cell carcinomas 
arise from parotid glands and remainder from submandibular gland.  
 
Gross: the tumour margins are usually poorly demarcated with infiltrating edges and rarely 
circumscribed. These tumours are firm to hard in consistency. Cut surface shows variegated 
appearance.  
 
Microscopy: The tumours are composed of infiltrating large sheets, ribbons, cords or nests of 
anaplastic cells. The tumours cells sre round to oval in shape, having minimal cytoplasm with 
hyper chromatic nuclei containing finely dispersed chromatin and inconspicuous nucleoli 
16) Other Tumours: 
a) Undifferentiated carcinomas: 
These are uncommon.  1 to 4.5% of  the malignant parotid tumours. Parotid  is  most 
common site then  submandibular and Minor salivary gland origin is extremely rare.  
Typically they demonstrate increased mitotic figures with a significant degree of 
cellular plemorphism. Because of the bizarre cells and the lack of organization into a 
recognizable arrangement, there is great difficulty is distinguishing the origins of the tumour, 
thus it is placed into the undifferentiated category. 
b) Malignant lymphoma: 
Primary milagnant lymphoma of salivary glands is rare and virtually always occurs in 
parotid gland, divided into 2 sub groups: 
1. Arising in the intra parotid and Para parotid nodes, 
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2. Salivary parenchyma. 
Primay nodal lymphoma presenting as a parotid lesion is often a stage I lesion and is 
associated with a good prognosis. Parenchyma lymphomas usually arise in the setting of 
lymphoepithelial lesions with or without sjogren’s syndrome 62. 
 
c) Metastatic Carcinoma: 
Reach the gland by direct spread, lymphatic or haematogenous spread.  Malignant 
melanoma and squamous cell carcinoma of  mucosa of  upper aero digestive tract via the 
lymphatic’s account for 80% of the parotid metastasis. Haematogenous spread is most often 
from carcinoma of the lung, kindney, breast and colon. 
COMMON SOFT TISSUE TUMOURS OF THE SALIVARY GLANDS 
1) Haemangioma : 
Haemangioma accounts for 50% of all parotid tumours in children. It is uncommon in 
other salivary glands and in adults. The capillary heamangioma are probably neoplasm or 
vascular malformations, where as the cavernous haemangioma are best regarded as reactions 
to trauma or else vascular malformations. The capillary haemangioma show the modest 
female predominance. 61% are present at birth and 86% appear within the first month  
Gross: structure of an excised specimen of a capillary haemangioma reveals a spongy purple 
lobular mass, which infiltrates the gland.  
Microscopic: Shows endothelial proliferation with vascular differentiation, which is the 
hallmark of this disease. Microscopic examination of cavernous haemangioma reveals dilated 
blood vessels and sinuses lined by endothelium. It is un-encapsulated and infiltrating.73,74 
2) Lymphangioma: 
Lymphangiomas (cystic hygromas) were first recognised as being of lymphatic origin 
in  1828. These vascular malformations are not true neoplasm. Salivary gland involvement is 
very rare.  
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Gross: Reveals a spongy, cystic multi-loculated lesion containing fluid that is either cloudy 
or yellow tinged.  
Microscopy: Demonstrates endothelial lined spaces with a connective tissue stroma.  
3) Lipoma: 
Lipomas are uncommon and account for 0.6 to 4.4% of all parotid tumours. They are 
less common in the submandibular gland. They most commonly occur in the fifth to sixth 
decades and are rare in children.  
Gross: Reveals them to be smooth well demarcated and yellow.  
Microscopy: shows them to be composed of mature fat cells with an enveloping capsule. In 
pure form, fatty infiltration is referred to as lipomatosis. Glands displaying acinar cell 
hypertrophy with or without fatty changes have been called sialosis, sialoadenosis or 
nutritional mumps74.  
4) Neurofibroma: 
This tumour also arises from the Schwann cells but behave much differently. This 
may be solitary or part of neurofibromatosis. They are usually present as encapsulated 
lobulated swelling.74  
Based on an institutional data from 1990 to 1997 Brandon G. Bentz et al, indicates 
that less than 5% of the neoplasm, benign or malignant present in patients who are 16 years 
of age or younger. Several features distinguish the neoplasm in this age group, as compared 
those in adults:  
• A much greater frequency of non epithelial tumours, parotid haemangioma are most 
common.  
• Preponderance of parotid gland involvement  with submandibular glands74,75 
TUMOURS OF MINOR SALIVARY GLANDS  
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Tumours of the minor salivary glands comprise less than 2% of all tumours of the 
head and neck, and 37% to 48% of these arise from the palate. Minor salivary gland tumours 
also occur in the upper lip, buccal mucosa, pharynx, larynx, nasal cavities, and sinuses. Minor 
salivary gland tumours of  hard palate have a propensity to arise at  junction of  hard and soft 
palates, followed by  hard palate.  
Age and Sex Incidence: 
• There is a slight preponderance of lesions in females, with a peak incidence in the 
third to fifth decades. Despite their relative rarity among head and neck neoplasm, 
minor salivary gland tumours continue to generate notable academic interest, likely 
due to their potential for aggressive behaviour.  
Histology: 
• Adenoid cystic carcinoma, adenocarcinoma, and mucoepidermoid carcinoma have  
been refered as  most common malignant tumour of  palatal minor salivary glands. 
Other malignant tumours encountered include low grade polymorphous 
adenocarcinoma, carcinoma ex pleomorphic, acinic cell carcinoma, and 
undifferentiated carcinoma.  
• The majority of benign minor salivary gland tumours of the palate are pleomorphic 
adenomas, with scattered monomorphic adenomas and basal cell adenoma.  
CLINICAL FEATURES 
The appearance of a lump in or near  salivary glands is  most common mode of 
presentation which may or may not be associated with pain.  
The salivary gland swellings can be presented as acute inflammatory condition, 
chronic inflammatory condition, calculus diseases, a benign or malignant tumours, manifest 
as congenital abnormalities or represent involvement of systemic disorders of various 
salivary glands. So the clinical features of these are considered individually.76,54,39 
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1. Acute Suppurative Sialadenitis: 
The clinical presentation of acute salivary infection is sudden onset of pain and 
swelling overlying the affected gland. It most commonly affects the parotid gland. 
Examination reveals indurations, erythema, edema and extreme tenderness over the affected 
gland.  
2. Chronic Recurrent Sialadenitis:  
Chronic recurrent sialadenitis may follow an acute of suppurative sialadenitis. The 
recurrent attacks of pain and swelling usually associated with eating and drinking and 
accompanied by the discharge of flecks of pus in the saliva. The disease is much more 
common in the parotid salivary gland.  
3. Sjogren's Syndrome: 
It is  autoimmune disease,  symptoms and signs were first described by Hadden 
in1883.Sjogren's syndrome has been classified into primary and secondary.  
Sjogren's syndrome described by Sjogren's in 1933.  Triad of dry eyes, dry mouth and 
rheumatoid arthritis. The combination of dry eye and dry mouth  without connective tissue 
disorder is known as primary Sjogren's syndrome. The combination of dry eye, dry mouth 
and rheumatoid arthritis is called as secondary Sjogren's syndrome 38,78. 
4. Granulomatous Diseases:  
They may occur with or without systemic manifestations. Generally both parotids 
enlarge simultaneously, and submandibular, sublingual and lachrymal gland may involve. 
Granulomatous disease may present as  
a. Mycobacterium infections: presenting as tumour like swelling with little pain.  
b. Cat scratch disease: In these condition children are mostly affected. Cervical 
lymphadenitis and mild pyrexia is present which is self limiting.  
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5. Viral Infections:  
Mumps is  most common viral disease to involve  salivary glands. It is commonly 
recognised in  4 to 6 year old age group. The incubation period is 2 to 3 weeks.  
Clinical onset is characterised by pain and swelling in one or both the parotids. Systemic 
symptoms include fever, malaise, myalgia and headache and usually resolve before the 
parotid swelling. One episode of infection confirms lifelong immunity38. 
6. Sialolithiasis: 
Calculi may form in any of the salivary glands. The submandibular gland is the most 
common (80%), parotid gland (20%) followed by sublingual glands and minor salivary 
glands (1-2%) follow at a lower rate of recurrence. 
Commonly,  patient gives  history of recurrent swelling and pain in  involved gland,  
associated with eating. With repeated episodes, infection may intervene. Occasionally patient 
will present with a stone that is palpable in the salivary duct without any history of salivary 
swelling or inflammation.  
7. Cystic Lesions:  
Congenital cysts usually manifests immediately after birth or in the childhood. 
Presents as  fluctuant swelling both in  floor of  mouth and in  submandibular triangle. 
Acquired cysts are usually dominated by the clinical features of the causative agent 
such as calculus, neoplasm, trauma, parotitis etc 82.  
8. Sialadenosis: 
Painless diffuse enlargement of  salivary glands, either unilateral or bilaterally, most 
commonly associated with metabolic disorders, nutritional deficiencies and reaction to some 
drugs. Parotid gland is involved commonly43.  
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9. Mucoceles:  
 Ranula tends to occur most frequently in  second and third decades of life, with  age range of 
3 - 61 years.  
Ranulae are usually either one-side or  other in  floor of  mouth and 2 - 3 cm in 
diameter. Occasionally, they extend across the whole of  floor of  mouth. A ranula is most 
commonly observed as a bluish cyst located below the tongue. It may fill  mouth and raise  
tongue. Typically, these are painless masses that do not change in size in response to 
chewing, eating or swallowing but may interfere with these functions (speech or chewing / 
eating). Occasionally, pain may be involved.  
10. Clinical Features Of Salivary Neoplasm  
Clinical feature of salivary neoplasm can be described under following headings.  
1. Rate of growth of the swelling: The average duration before seeking treatment is 
described as 4-5 years by different authors for a benign tumour. The duration in 
carcinoma is in months rather than years. The rate of growth varies greatly from 
tumour to tumour and even in the same tumour from time to time.  
2. Pain: benign tumours of the salivary glands are painless. Pain is the most presenting 
symptom in cases of malignant tumours. Sudden onset of pain in a mixed salivary 
gland tumours always denotes some complication like malignancy. Pain is of dull, 
boring when present. It is usually localized to the region of the tumour. Sometime 
pain may be referred to the corresponding ear, along the branches of auriculotemporal 
nerve.  
3. Facial palsy: Facial nerve is never involved in benign tumours, however large the 
tumour may be. Involvement of the facial nerve in the course of mixed tumours 
always indicates a malignant change. In cases of carcinoma the most striking and 
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important clinical manifestation is facial palsy. But absence of facial palsy does not 
rule out possibility of the tumour being malignant. 
 
4. Ulceration: benign tumours never ulcerate. Ulceration of benign tumours occurs 
when they turn malignant or when some counter irritant applied to the tumours. In the 
advanced cases of carcinoma, skin may be fixed, reddened, and give rise to ulceration  
Signs of Salivary Tumours:  
1. Swelling: The characteristic features of the swelling are globular or ovoid in shape, 
well defined margins; surface is lobular and nodular in some cases. Rarely the 
swelling may be diffusing in parotid gland and submandibular gland tumours,  where 
as it is common feature in sublingual and minor salivary glands.  
2. Local invasion: In advanced carcinoma, skin may be fixed, reddened and give rise to 
ulceration. Tumour is often fixed to the underlying deeper structure (external auditory 
canal, mastoid tip, zygomatic arch, mandible, masseter muscle, pterygoid muscles or 
sternomastoid). The TM joint should be examined for signs of direct tumour 
extension. 
3. Nodal involvement: Regional lymph nodes are never enlarged in benign tumours, 
lymph node metastasis occur when these turn malignant, commonest lymph node that 
are enlarged are upper deep cervical group, submandibular and sub mental group. 
Regional metastasis correlates strongly with a diminished overall survival 86. 
4. Oral cavity examination should include inspection of duct opening for evidence of 
abnormal or purulent drainage. These findings are more often associated with 
inflammatory disease. Trismus should be identified because it may be indicative of 
invasion of the masseter or pterygoid muscles. The oropharynx must be carefully 
evaluated for signs of parapharyngeal space involvement. Typically this will be 
manifested by a sub mucosal bulge in the soft palate or tonsillar regions83. 
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A complete head and neck examination is essential. Malignancy below clavicle  
present as metastasis in  parotid gland years after  initial disease (e.g. breast, lung and 
kidney). Note: non-Hodgkin's lymphoma is a likely diagnosis in elderly 83,84,85. 
Clinical features of specific neoplasms:  
A.  ‘Pleomorphic adenoma’ :  
This is  commonest benign salivary gland tumour and is virtually  only benign 
neoplasm to occur in submandibular, sublingual and minor salivary glands. PA present as 
slow growing painless mobile, firm and circumscribed mass. If  arises in  deep lobe of  
parotid gland it may present as parapharygeal mass. There is seldom any compromise of 7th 
nerve. Most tumours are located in the tail of the parotid gland, also in other parts of  gland. 
10% of  PA occurs in  deep lobe of  parotid gland. Incidence of recurrence after 
parotidectomy in PA is 5%.  
Incidence of malignant transformation is 3 - 15%. Except for recurrence prognosis is 
excellent. Recurrence in PA may be due to (1) Inadequate surgery  
(Enucleation) (2) Inadvertent spillage (3) Tumour removal with inadequate margin (4) 
Multicentricityl1.  
B. Warthins tumour(WT) : 
WT present as well defined, soft to firm mass. It is usually asymptomatic. However, 
18% of patients in the series complained of pain, and there has been one report of facial 
paralysis. Characteristically arises in  inferior pole of  parotid gland and occasionally 
originates in  lymph nodes adjacent to that part of the gland. This tumour scans 'hot' with 
technetium51.  
C. Oncocytoma:  
It accounts for less than 15% of all salivary gland tumours. It usually occurs in  
parotid gland and is quite unusual elsewhere. It presents as well defined, lobular mass with 
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firm to hard consistency. In reported series, bilaterally and multi-centricity have been 
conspicuous. Most tumours occur in the 6th decade. There is 2:1 F: M ratio. This is one of 
salivary gland tumours that scan 'hot' with technetium53.  
D. Mucoepidermoid tumour:  
Attention is usually drawn to a painless solitary enlargement of the body or tail of the 
parotid gland or the submandibular gland. Duration usually averages less than 1 year.  
The tumour is relatively well circumscribed and movable, and it may mimic a mixed 
tumour. Pain, facial paralysis, and fixation to the overlying skin are not common but when 
present are usually harbingers of high grade lesions. High-grade tumours have a high 
recurrence rate (15-75%).  
E. Acinic cell tumour:  
Tumour growth is usually slow; rarely may they have a more rapid enlargement. Pain 
or tenderness is experienced frequently. Facial nerve paralysis is infrequent but is an ominous 
prognostic sign. It is generally regarded as a low-grade malignancy87.  
F. Adenoid cystic carcinoma: 
Typically it grows slowly. Pain and tenderness generally occur during the course. 
Fixation to skin and the surrounding deeper structures develops in the later stages. Regional 
lymph nodes involvement is found in 10-15% of cases. Distant metastasis to lung and bone 
occurs late in the course of the disease56.  
G. Adenocarcinoma:  
About 25% of patients complain of the effects of the nerve involvement. Facial nerve 
irritability occurs first and muscle spasm can be produced if the tissues over the nerve are 
trapped. A few patients present with skin involvement. The risk of lymph node metastasis is 
24 - 36%70. 
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H. Malignant mixed tumor:  
Long history of slow growing parotid swelling, with recent rapid growth brings them 
to medical attention. Pain, skin ulceration, facial nerve weakness, attachment to skin, and 
telangiectasia can occur and should lead the clinician to suspect malignancy in a mixed 
tumour.  Pain has been described in 4 to 55% of patient, and appears to be more common in 
submandibular gland tumours52. 
I. Miscellaneous malignant tumours:  
a. Squamous cell carcinoma: It grows rapidly and half of the patients have metastatic 
lymph node involvement at the time of presentation. It causes pain, facial nerve paralysis, 
commonly associated with early skin fixation and ulceration59 
b. Malignant lymphoma: Primary lymphomas are uncommon. Occur in the 5- 6TH  decade 
of life, F>M, H/O Sjogren's syndrome or arthritis is elicited in majority of patients. They 
run an indolent clinical course where as lymphoma arising in intra salivary gland lymph 
nodes usually present as rapidly enlarging swelling within the gland62. 
c. Undifferentiated carcinoma: they are highly malignant. Approximately 33% have 
partial or total facial paralysis 40% beyond the parotid on presentation. 13% present with 
regional metastasis61. 
J. “Tumours of Minor Salivary Glands”: 
Most of  tumours are detected by the patient as an asymmetric swelling of the palate; 
sometimes tumours are completely asymptomatic and were detected only on routine dental 
examination. Other symptoms encountered include pain, ulceration, and dysesthesias.  
A painless swelling of the palate is the most common presenting symptom for 
tumours of the palatal minor salivary gland tumours. Both pain alone and neural complaints 
including pain and dysesthesias exhibit a statistically significant association with a 
histopathologic diagnosis of adenoid cystic carcinoma.  
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Some common soft tissue tumours of the major salivary gland: 
a) Haemangioma (capillary or cavernous): most often presents during childhood and 
accounts for almost half of the hamartomatous and neoplastic parotid lesions seen in 
this age group. The capillary haemangioma are far more common. Lymphangiomas 
are painless, trans-illuminate, and usually slowly enlarging. 50% of them present at 
birth. There is an equal sex distribution.  
b) Schwannoma, neurofibromas are slowly growing tumours with an equal sex 
distribution. Paraesthesias are common, it is tender, 50% of these have facial 
weakness when seen74.  
DIFFERENTIAL DIAGNOSIS  
1) Sialadenosis refers to non inflammatory and non neoplastic Salivary gland 
enlargement. When the tumour begins it is very difficult to differentiate from calculus 
disorders, inflammation etc, especially when these are Unilateral and small.  
2) Enlarged lymph nodes within the parotid gland or cervical region may be mistaken for 
a gland tumour. Hence, it is very important to examine all the drainage areas, to rule 
out any other cause.  
3) Lipomatous pseudo hypertrophy of a gland can be mistaken for a tumour. This 
happens because of infiltration of the gland by fatty tissue.  
TNM STAGING OF SALIVARY GLAND TUMORS (1997):” 
Proposed Staging System for Major Salivary Gland Cancers by American Joint 
Committee For Cancer Staging (AJCC). 
T Primary Tumour 
TX Primary Tumour Cannot be Assessed. 
T0 No Evidence of Primary Tumour. 
T1 Tumour 2 Cm of less in greatest dimension without extraparenchymal Extension. 
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T2 
Tumour more than 2 cm but not more than 4 comes in greatest dimension without 
extraparenchymal extension. 
T3 
Tumour having extraparenchymal extension without seventh nerve involvement 
and/ or more than 4 cm but not more than 6 cm in greatest Dimension. 
T4 
Tumour invades base of the skull, seventh nerve and / or exceeds 6 cm in Greatest 
dimension. 
N Regional lymph nodes 
Nx Regional lymph nodes cannot be assessed. 
No No regional lymph node metastasis. 
N1 N1 Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest Dimension. 
N2 N1>3and <6 cm, or bilateral or contralateral lymph nodes. 
N2a Single ipsilateral node > 3 cm, < 6 cm in diameter. 
N2b Multiple ipsilateral node, none > 6 cm. 
N2c Bilateral or contra lateral nodes, none > 6 cm. 
N3 Metastasis in a lymph node more than 6 cm in greatest dimension. 
M Distant Metastasis 
Mx Distant Metastasis cannot be assessed. 
M0 No distant Metastasis. 
M1 Distant Metastasis. 
 
“STAGE GROUPING” 
Stage I T1 N0 M0 T2 N0 M0 
Stage II T3 No Mo 
Stage III T1 N1 M0 T2 N1 M0 
Stage IV 
T4 
T3 
T4 
Any T 
Any T 
Any T 
Any N 
N0 
N1 
N1 
N2 
N3 
 
M1 
M0 
M0 
M0 
M0 
M0 
 
INVESTIGATIONS:- 
Acute inflammatory conditions generally can be diagnosed by history and physical 
examination alone, whereas chronic inflammatory diseases, granulomatous disease and 
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neoplastic disorders require supplemental diagnostic information including laboratory tests, 
images studies, or biopsy54. 
With careful history and physical examination, it is not difficult to diagnose a case of 
salivary gland swelling. Apart from the routine blood examinations, the following 
investigations are commonly used for diagnosis of salivary swellings89,90. 
1. Plain X-ray 
2. Sialography 
3. Radiosialography 
4. Ultrasonography 
5. Computed tomography 
6. Magnetic resonance imaging  
7. FNAC, Biopsy  
1. Plain X Ray: 
• Most submandibular calculi are radio opaque and about 94% can be diagnosed by the 
plain x ray taken in intra oral view. Stones in the superior gland or proximal 
Wharton's duct may be hard to visualise on plain lateral projections radiographs 
because the stones may be superimposed on the teeth or mandible.   Anteroposterior 
view with  mouth open  allows visualisation. 
• Parotid stones are more likely to be  radiolucent and nearly 40% can be diagnosed by 
plain X ray.  
2. Sialography: 
Sialography is  used to evaluate calculi, obstructive disease, inflammatory lesions, 
penetrating trauma and mass lesions. Sialograms are  effective in finding ductal and 
intraglandular calculi.  
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Equipment: 
To perform a sialogram, the following equipment should be available, water soluble 
contrast media, such as meglume diatrizote 76%, a good light source, a topical anaesthetic for 
ductal orifice, lachrymal dilators, a lachrymal cannula,a syringe, polyethylene tubing, a 
Rabinov cannula, and a tapered side hole needle.  
USE:  
It helps in detection of occlusion of the duct, a salivary cutaneous fistula or a salivary 
oral fistula or development of a sialocele. 
Disadvantages:  
• It may cause infection or inflammation. 
• Extravasations of the dye may result in severe inflammatory reaction preventing a 
clear demarcation of clear tumour margin and may also delay the planned surgical 
procedure and high pressure generated during the procedure disseminates the tumour 
cells. 
Contraindications:  
• Acute sialadenitis and in patients with allergy to iodine. 
3. Radio Sialography:  
Current radioactive scanning of the major salivary glands is done with technetium  
tetra-oxygenated form-pertechtenate. Radio isotope scanning is used for evaluation of the 
parenchymal function and detects mass lesions. It is used for detecting mass lesions of the 
parotid and submandibular gland. Scanning has little to offer in the evaluation of the sub 
lingual and minor salivary glands. The scan should be performed in the resting state because 
uptake in the parotid is greater. 
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Ultrasonography: 
Bozin et al (1971) first reported the use of ultrasonography to study the salivary 
glands. High resolution ultrasound (7.5-10 MHz) helps in differentiating intra-glandular from 
extra-glandular tumours and benign from malignant tumour, where in benign show variable 
reflectivity with well defined borders, malignant tumour show low reflectivity with poorly 
defined border and Inflammatory lesions show high reflectivity with diffuse borders. In a 
study from Spain, specificity and sensitivity for malignancy was 96.4% and 81.8% 
respectively.It is  also used to delineate whether the mass is cystic or solid. 
Ultrasound imaging also helps in direct needle aspiration of parotid abscess. It is also 
used to localise the calculus. As many as 90% of the stones greater than 2mm in size can be 
detected as an echo dense spot in an ultrasound. 
4. Computed Tomography  
CT has largely replaced other diagnostic studies for the study of salivary masses, 
since 1979, when it was first introduced.  
CT scans delineate solid from cystic masses and can detect masses as small as lcm 
within the substance of the salivary glands. The anatomic delineation of a mass involving any 
of the salivary glands can be well defined by ct scanning. 
Byrne MN et al. Studied that CT scans of 110 resected parotid masses shows 
following characteristics:  
a) For tumours with clear borders, homogenous appearance and high signal density,  
diagnosis will be  benign  or  low grade malignant tumour. 
b) For tumours with ill defined borders, heterogeneous appearance and high density,  
diagnosis will be high grade malignant tumour. 
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c) Ill defined borders, heterogeneous appearance and mixed signal density will be 
consistent with an inflammatory process.  
This is a valuable supplement to MRI in evaluating the bone adjacent to tumour. CT 
combined with sialography is excellent for differentiating intrinsic from extrinsic masses, 
benign from malignant masses, superficial from deep lobe tumour and showing the 
relationship of the mass to the facial nerve.  
5. Magnetic Resonance Imaging: 
It is superior to CT for better identification of internal architecture of the gland and 
better definition of tumour border. It provides direct multi-planar imaging without the need 
for contrast agents and ionizing radiation. Recent advances in MRI are gadolinium (a Para-
magnetic compound which enhances vascular lesions) and MRA.  
The contrast between the tumour and surrounding tissue is greater than with CT 
scanning but tissue details are less well defined. 
• It helps in differentiating benign from malignant nature of salivary tumour by 
knowing margin (smooth/infiltrative), solid/cystic, necrosis or hemorrhagic areas 
within the tumour and malignant tumour show gadolinium enhanced images.  
• Deep lobe tumour of parotid can be differentiated from a parapharygeal mass, 
wherein later shows fatty plane all around, but parotid tumour shows attachment to 
the superficial lobe. Also helps in differentiating postoperative fibrosis from recurrent 
nodules.  
Disadvantage: 
• It does not show stone and bone. Many attempts to determine benign from malignant 
nature have shown misdiagnosed interpreting benign as malignancy(CT-39% and 
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MRI-35%). The consensus is that MRI cannot be used confidently to distinguish 
benign and malignant masses.  
Indication of CT/MRI:  
• Malignant or recurrent tumours  
• Big neoplasm  
• Doubtful carotid artery involvement  
• Involvement of local structure (including nerves which  suggest inoperability). 
 
6. Radio-nucleotide scan (PET) 
It is done using technetium 99m (t1/2 is 6'/2 hours). Scan is performed in resting state 
because uptake in parotid is greater. Little useful in other salivary glands. Warthins and 
oncocytoma show hot spots. Also helps in differentiating benign from malignant tumour on 
basis of malignant lesions having higher metabolic rate and increased incorporation of radio-
labelled deoxy-glucose than benign lesions.  
 
7. CT Sialography 
It is found that useful in tumour mapping preparation for surgery. Specifically the 
tumours location in relationship to deep lobe, facial nerve and the Para pharyngeal space can 
be assessed. CT sialography cannot definitely diagnose or rule out the malignancy to avoid 
the need for surgery.  
8. Biopsy 
FNAC:  
It is a simple and reliable method for obtaining the tissue diagnosis of salivary gland 
Swellings. The diagnostic accuracy with regard to the benign versus malignancy is about 
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98% for benign salivary gland swellings, 93% for primary malignant salivary gland 
swellings, and 88% for metastatic tumours.  
This helps in proper counselling of patient regarding surgery and preoperative 
evaluation which will vary according to whether the mass is primary, neoplastic or lymphoma 
or metastasis. If malignancy is found, further imaging can be done and non neoplastic causes 
of salivary swelling can be treated without surgery.  
Advantages and Uses: 
1. FNAC is usually an office procedure. It is less laborious and cost effective. 
2. It is safe, less traumatic and better tolerated by the patients. 
3. It is rapid and results are available in less than 20-30 min and the procedure can be 
repeated as often as necessary. 
4. In certain tumours the smears can be easier to interpret than histological sections.  
5. It produces enough cellular material for various auxiliary studies (DNA, molecular 
analysis and immunohistochemistry studies).  
Complications of FNAC: 
There is a possibility of lymphatic, haematogenous and canalicular dissemination. But 
this does not have any clinical implication. Several studies have failed to report any such 
cases. Infection is minimal due to aseptic precautions.  
Limitations: 
1) Specific diagnostic conclusions may not always be reached. Aspirates from MEC, 
Lymphoma and sometimes PA also give some diagnostic difficulties 
2) Definitive diagnosis is not drawn if the sample is inadequate or the representative  
area is not aspirated properly.  
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3) Practice and skill in aspiration techniques are necessary. 
4) Experience is required for accurate interpretation.  
5) Diagnostic information is limited.  
• Sensitivity is 93.3-95.7% (98% for benign; 93% for primary malignancy; 88% for 
metastatic tumour).  
• Specificity is 98-100%. Lay field et a land Young GA et al found high diagnostic 
efficiency of FNAC in Salivary gland tumours.  
Open biopsy: is rarely performed because of risk of injury to facial nerve and tumour  
implantation and tumour recurrence with both benign and malignant tumours. As a result of 
high diagnostic Accuracy of FNAC open biopsy is almost contraindicated now days.  
Frozen section:  It is used to assess the margins of resection.  
TREATMENT: 
Management of the salivary gland swelling depends on the pathology of the  swelling. 
Treatment of Inflammatory and non inflammatory, non neoplastic disease of salivary glands 
is dependent upon  diagnosis and includes antibiotics, supportive therapies, symptomatic 
management, and Surgical and non surgical interventions. Whereas the surgery is the 
mainstay of treatment of both Benign and malignant salivary gland tumours. Adjuvant 
radiation therapy is administered in selected malignant salivary gland tumours and 
chemotherapy may have palliative benefit in uncontrolled malignant neoplasm.  
Treatment of Inflammatory and Non Inflammatory Non-Neoplastic Diseases: 
1. Acute Suppurative Sialadenitis: 
Treatment of the acute sialadenitis is directed at reversal of the underlying medical 
condition responsible for infection. If the patient presents at an early stages before abscess 
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formation, the infection can usually be controlled by anti-biotics, warm packs and 
rehydration. Incision and drainage is advised if infection does not subside with in 48 hrs with 
a small incision taken over the most prominent part of the swelling, usually incisions are 
taken superficially and parallel to the facial nerve branches, pus is drained out by a sinus 
forceps . 
2. Chronic Sialadenitis: 
Chronic sialadenitis is more common in submandibular salivary gland and the capacity of 
the gland to recover is usually is very poor following infection, the gland itself should be 
removed.  
3. Sjogern's Syndrome:  
Treatment of Sjogren's syndrome remains largely empirical and symptomatic, and no 
clinical trial has been proved capable of changing the course of the disease. Patients with 
keratoconjunctivitis should avoid windy or dry climates, dust or smoke. Oral hygiene after 
meals avoidance of sugar containing foods is important for the prevention of dental disease. 
Artificial tears are essential to protect cornea Pilocarpine hydrochloride a saliva secretogauge 
(5mg 3-4 times a day) can be administered for the treatment of xerostomia. Patients are 
advised to carry water bottles for frequent drinks. Diuretics, antihypertensive drugs and anti 
depressants should be used with care.  
4. Granulamatous Disease:  
Granulamatous disease should be treated according to the pathology and moreover 
some of them are self limiting and resolve without treatment38.  
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5. Mumps:  
Treatments of viral salivary gland infection are primarily supportive, including rest 
and adequate hydration, since disease is self limiting. The most significant advancement in 
the treatment of mumps is prevention in the form of vaccination commonly combined with 
measles and rubella vaccine. A single subcutaneous dose after 12 months of age confers 
lifelong immunity77.  
6. Sialolithiasis:  
The anatomy of the salivary glands and it’s ducts is very pertinent to determine the 
mode of therapy for sialolithiasis. Submandibular stones are treated surgically either through 
a transoral sialolithotomy approach or through a complete sialaldenectomy through a extra 
oral approach. If the stones are palpable it can be removed via Trans oral route, especially 
anterior stone which are palpable. For very anterior stone filleting the submandibular duct is 
considered the best approach. This can be done under a topical or local anaesthesia. Stones in 
a slightly more anterior position may be amenable to modification of trans oral.Approach 
where the stone is cut down directly. Deeper submandibular stones are generally removed 
through sialadenectomy. 
Parotid calculi is more problematic, parotidectomy remains  mainstay of surgical 
management of  majority of cases. 
Extracorporeal lithotripsy is a new modality that was introduced iin the early 1980s 
and has revolutionised the treatment of urinary stones. Iro H et al (1989) first reported the use 
of extracorporeal lithotripsy for the parotid stones. Extracorporeal lithotripsy can be 
performed without the need for local or general anaesthesia. Extracorporeal lithotripsy 
appears to be the most effective for the treatment of parotid stones compared to 
submandibular stones.  
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7. Cystic Lesions:  
True cysts are more common in the parotid. The cysts may be acquired or congenital. 
Excision during a quiescent period with preserved  facial nerve is curative.  
8. Sialadenosis:  
Mechanism of asymptomatic enlargement of parotid gland is unknown. The is 
generally good if the underlying disease can be corrected and the parotid gland generally 
returns to norma143. 
9. Salivary Gland Tumors  
Treatment  
In formulating  treatment plan, following points affecting Prognosis:  
1. Histopathological diagnosis.  
2. Lymphnode metastasis.  
3. Facial nerve paralysis.  
4. Skin involvement. 
5. Recurrent tumour. 
6. Distant metastasis.  
7. Irradiation sensitivity.  
SURGERY  
Surgery is the main stay of treatment for salivary gland tumours, both benign and 
malignant. Surgery For salivary gland tumours never really developed until World War II 
Due to fear of injuring the Nerves and partly also due to the ever present risk of spreading 
infection along facial planes, during the pre-antibiotic era.  
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• Principles of surgery on salivary gland tumour:  
1. “Removal of entire tumour mass should be achieved in toto, without breaching 
capsule or producing spillage.” 
2. “The integrity of important nerves should be maintained when practicable. We have 
to identify facial nerve and its branches by meticulous dissection”. 
3. “Avoidance of parotid duct injury which may lead to salivary fistula” 
Surgery for Parotid Gland 
Procedures: 
1) Superficial parotidectomy:  
Definition:  
Superficial parotidectomy involves removal of only superficial lobe of  parotid gland.  
Indication: All benign parotid tumours confined to superficial lobe.  
2) Conservative Superficial parotidectomy:  
     Here 7th cranial nerve is conserved after open dissection. 
Indications:  
Only superficial lobe lesion with facial nerve at distance. 
3) “Total conservative parotidectomy”:  
This involves removal of both  outer and inner parts of  parotid salivary gland, which 
are separated by  nerve that moves  face, while avoiding damage of  nerve.  
Indications:  
1. Conditions involving the deep lobe or both the outer/ superficial and the deep part of the 
gland:  
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• Usually benign deep lobe pleomorphic adenoma or large dumb bell shaped 
pleomorphic adenomas involving both lobes.  
• Recurrent pleomorphic adenoma. 
• Malignant parotid neoplasms without preoperative facial nerve palsy and where 
tumour can be separated off from the nerve. 
• Small intraglandular deep lobe malignant tumours.  
• Other benign progressive conditions involving the whole gland such as recurrent 
severe suppurative parotitis secondary to intraglandular stones or ductal narrowing.  
2. Conditions requiring access to deep structures whilst preserving the facial nerve, eg, 
parapharyngeal space or infratemporal fossa tumours not involving the facial nerve.  
4) “ Total Radical Parotidectomy” :  
Involves removal of both the outer and inner part of the parotid salivary gland (which 
are separated by the nerve that moves the face) as well as the facial nerve. A neck dissection 
may be performed at the same time.  
Indication:  
• Preoperative facial nerve palsy. 
• If intra-operative evidence of gross infiltration or encasement of nerve by the tumor, 
even in presence of normal preoperative facial function.  
• Recurrent pleomorphic adenoma. 
• Conditions requiring access to deep structures where preservation of  facial nerve is 
impossible, eg, parapharyngeal space or infratemporal fossa tumours.  
5) “Extended Radical Parotidectomy” :  
This includes all the components of a total radical parotidectomy, as well as adjacent 
structures involved with disease. This may involve bone (lower jaw, jaw joint, mastoid), 
muscle (from the neck and face) and cartilage from the ear canal. Total radical parotidectomy 
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involves removal of both the outer and inner part of the parotid salivary gland (which are 
separated by the nerve that moves the face) as well as the facial nerve. A radical or modified 
radical neck dissection is usually performed at the same time.   
Indications: 
• Conditions involving  deep lobe or both the outer/ superficial and the deep part of the 
gland, as well as adjacent structures.  
• Recurrent pleomorphic adenoma after repeated revision operations where nerve goes 
through recurrent tumour and involves adjacent structures such as skin, muscle and 
cartilage.  
Facial nerve identification during parotid surgery: 
The most constant landmark for  facial nerve is at  stylomastoid foramen, between 
styloid and mastoid process. During routine parotidectomy, however, complete access to this 
region is difficult. The following landmarks and techniques can be used for identification of 
the facial nerve.  
• l cm deep, lcm inferior and lcm anterior to triangular end of tragus called trigonal 
pointer.  
• More constant landmark is tympano-mastoid suture line. It is a groove that is easily 
Palpated between mastoid and tympanic portions of the temporal bone. Nerve exits 
from stylomastoid foramen 7 mm medial to suture line.  
Surgery for the Submandibular Gland  
1. Total excision: 
Indication: All benign and malignant tumours of submandibular gland.  
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2. The commando operation: 
Indication:  
Malignant submandibular tumour which is fixed to the mandible with cervical lymph 
node metastasis. 
Surgery for the Sublingual Gland  
1) Treatment of Ranula:  
a)  Aspiration. 
b) Excision with removal of gland.  
c) Marsupialisation. 
Surgery of Minor Salivary Glands:  
The treatment of choice of minor salivary gland neoplasm is surgery. Surgical 
approach to  tumours depends on  site and histology of  tumour. Neck dissection are 
recommended for clinically positive necks and in those with high grade tumours. Similarly 
radiation is used as adjuvant therapy in high grade tumours.  
• Low grade malignant tumours of the palatal mucosa such as pleomorphic adenoma 
and low grade mucoepidermoid carcinoma and adenocarcinoma is usually treated by a 
soft tissue excision with documented margins of 1 cm clinically uninvolved tissue 
around it's periphery and including the palatal periosteum followed by healing by 
secondary intention, palatal perioteum serves as an effective anatomical barrier, the 
palatal bone is not excised even if cupped out pressure resorption has taken place. 
• Malignant tumours of the palatal mucosa such as intermediate and high grade 
adenocystic carcinoma, wide excision in the form of partial or hemimaxillectomy is 
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done followed by radiotherapy for high grade lesions. Chemotherapy could also be 
used as an adjuvant. 
Management of the Neck Node: 
Comprehensive neck dissection either a MRND or RND is indicated when there are 
clinically positive nodes. Armstrong and associates in 1992, suggested elective treatment of 
neck in patient with  
• High grade tumours of any size or low grade tumours of at least 4 cm in size. 
• Dissecting level I, II and III to identify occult disease.  
COMPLICATIONS OF SURGERY  
The complication of salivary gland surgery can be summarized as follows:  
1. Injury to the Nerves  
a) The marginal mandibular nerve is the commonest to be injured at surgery for 
parotid gland and submandibular gland, because it is thinner than other branches and 
also it is more vulnerable, due to its proximity to surgical incisions. An Injury of this 
nerve produces drooping of the lower lip on the same side. This is called “wry neck”. 
b) Greater auricular nerve injury results in numbness of pinna, but some amount of 
recovery takes place due to overlapping by the surrounding sensory nerves in the 
neighbourhood. Recovery will take 6-9 months to occur.   
c) Lingual Nerve can be injured during surgery on the submandibular gland very rarely; 
this causes ipsilateral anaesthesia of the tongue. Still rarer is injury to the hypoglossal 
nerve, causing deviation of the tongue onto the same side.  
d) Facial Nerve: 7th cranial nerve dysfunction is common after surgery.  
Temporary facial nerve paresis is also common. 
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1. Facial Nerve Reconstruction 
A number of procedures are available to treat this, both nerve repair and plastic 
surgical correction. A Hypoglossal nerve transposition  (graft) can also be tried; temporalis 
and masseter muscle transfer are other alternatives. 
2. Haemorrhage and Hematoma:  
As the operative site is dependent area, collection of serum and blood is not 
infrequent.  
3. Gustatory Sweating:  Also called as freys syndrome. Sweating and flushing of facial skin 
after parotid surgery is the clinical feature.For treatment anti cholinergics and stellate 
ganglion blockade are tried.Superficial temporal artery fascial flap has better 
results.Botulinum toxin injection is also usefull. 
4. Parotid Fistula and Sialocele  
Definition: 
A parotid fistula is a communication between the skin and a salivary duct or gland, 
through which saliva is discharged. Parotid salivary fistula is a relatively common 
complication after parotidectomy.  
Pathogenesis:  
Salivary fistula or sialocele occurs if the resected edge of the remaining salivary gland 
leaks saliva and drains through the wound or collects beneath the flap (sialocele). Flow 
through the fistula increases during meals, particularly during mastication. In dubious cases, 
analysis of the fluid can confirm parotid secretion due to high amylase content.  
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Types 
a) Caused by the opening of Stenson's duct,  b) Sinus tracts originating in the glandular 
structure  
Treatment  
a) Aspiration and pressure dressings, b) Anti-Sialogogues, c) Radiation therapy,                              
d) Parasympathetic denervation, e) Cauterization of the Fistula, f) Reconstruction of the duct, 
g) Superficial or total parotidectomy with tract  
Conservative Management 
• A conservative modality is based on the regular aspiration of the content and 
compression dressing. This mode of treatment is mainly employed in sialocele. Anti-
cholinergic agents are used to suppress the glandular function during healing or in an 
attempt to close a fistula or a sialocele. Propantheline bromide is commonly used.  
• Radiation Therapy is especially considered for refractory salivary fistulas. It induces 
fibrosis and atrophy of the gland. Approximately 1800 rads for more than 6 weeks is 
required. 
Surgical Therapy: 
Surgical excision of  fistulous tract followed by right pressure dressing of  wound is 
an effective management option. 
Three operative techniques are described  
1. Repair of the duct over a stent  
2. Ligation of the duct  
3. Fistulisation of the duct into the oral cavity  
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Tympanic neurectomy:  
 Trans tympanic sectioning of the jacobson's nerve is done here.  
Botulinium Toxin Injection: 
Botox injections are usefull in managing sialocele and salivary fistula. 
4. Cosmetic deformity: 
Barely noticeable scar is possible with placement of the incision in skin fold. Another 
source of aesthetic concern is the depression or hollow resulting from the parotid gland 
resection, particularly following total parotidectomy.  
 
5. Recurrence: 
Occurs in both, benign and malignant tumour; may recur loco-regionally or present as 
distant metastasis upto 20 years after assumed curative local treatment. In case of 
pleomorphic adenoma recurrence has declined from the range of 20-30% to 0.7 %, as 
superficial parotidectomy has become the standard procedure.  
RADIOTHERAPY (RT): 
Major role is adjunctive to the surgery in form of postoperative radiotherapy, improve 
survival and cure rates (Armstrong J.G.). This will decrease the recurrence rate from 26.6 to 
9.1% (Guilla mondegui 0.M.1975). The indications for RT are: Postoperatively for all high 
grade tumors including adenoid cystic carcinoma. 
• Extra-parotid extension/perineural invasion (Locally advanced) - involvement of skin, 
nerve and bone.  
• Facial nerve involvement. 
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The radiation dose is 6000cgy in 30 fractions is given over 6 to 7 weeks.  
ACC is poorly sensitive to RT; so adequate surgical excision is the main stay of 
treatment.  
RT for inoperable tumour:  
Aim is to irradiate the planned volume to 6,500 CGY in 6 - 7 weeks giving daily 
Treatments of 200 CGY.  
CHEMOTHERAPY  
There is no established standard chemotherapy because of the lack of formal trails 
with adequate number of patients. Indications are limited to diseases that are metastatic or 
locally advanced and unresectable. The most commonly used drugs in combination CT are 
cisplatin, 5 Flurouracil & doxorubicin or 5-flurouracil, adriamycin and methotrexate has 
given variable success in some cases.  
Figure 1: Photograph of Modified Blair Incision 
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Figure 2: Photograph Showing Facial Nerve 
 
 
 
 
 
Figure 3: Photograph Showing Deep Lobe of Parotid Gland with Facial Nerves 
 
 
 
 
 
Figure 4: An Excised Speciment of Pleomorphic Adenoma of Parotid Gland 
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Figure 5: Photograph after Superficial Parotidectomy 
 
 
 
 
 
 
Figure 6: Photograph Showing Surgery of Submandibular Gland 
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METHODOLOGY 
This prospective study of consecutive cases of salivary gland swellings is based on 50 
cases admitted in various surgical units in Govt.Royapettah hospital and kilpauk medical 
college hospital Chennai  from Nov 2014 to Aug 2015.. 50 cases of salivary gland swelling 
are studied and data is presented here, which were analyzed and conclusion drawn, presented 
in tabular form with explanatory notes below each table. The statistics have been compared 
with different standard studies conducted on same subject by various authors around world.  
Inclusion criteria:  
• All patients admitted to surgical and surgical oncology wards of govt.royapettah 
hospital and kilpauk medical college hospital chennai  with salivary gland swellings 
due to obstructions of the salivary duct and neoplasia.  
• Patients who are willing for investigation and treatment.  
Exclusion criteria:  
• All saliyary gland swellings arising as a result of congenital conditions. 
• Salivary gland swellings arising as a result of inflammation. (ex. Mumps, Parotitis). 
• Salivary swellings associated with systemic diseases. (Sjogren's syndrome). All 
patients admitted were evaluated by documenting the history, through clinical 
examination, routine laboratory investigations and specific investigations. In history, 
importance was given to presenting complaints, duration of lump, rapid increase in 
size,associated symptoms of facial nerve involvement, previous surgical treatment or 
any medical problem. Associated medical conditions like diabetes, hypertension and 
anemia were managed and controlled before surgery with the patient's advice.  
74 
 
As a part of general work up of surgery in all patients, hemoglobin level, bleeding 
time, clotting time, urine, sugar albumin, microscopy, chest screening, ECG, Blood urea, 
serum Creatinine, RBS was estimated. Specific investigations like FNAC, X-rays of 
Mandible were done for all patients in the study group. Ultrasound, Sialography, C T Scan, 
MRI was not done for any of these patients in the study group, as there was no facility for 
these investigations in the hospital and because of the poor economic backgrounds of the 
patients.  
After evaluation of the swellings by clinical examination and by specific 
investigations, a surgical plan was formulated. The final decision was taken per operatively 
by the surgeon. The required specimen was sent for histopathologocal examinations. 
Appropriate antibiotics and analgesics are administered post operatively for all cases. 
Drainage tube was removed when the drain was less than 20m1 and sutures were removed on 
5th day.  The adjuvant treatment was decided depending on the final HPE report.  
Different modalities of treatment adopted in this study are 
1. Surgery alone 
2. Surgery and post operative radiotherapy  
The follow up period of these patients ranged from 1 month to 10 months. All patients 
were asked for follow up after 15 days of surgery then every month  to detect morbidity and 
recurrence. Long term follow up is necessary to study the actual prognosis of the patients and 
tumour recurrence and to know the ideal mode of treatment for each condition which was not 
possible in this study. Statistical analysis was done with SPSS software. 
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RESULTS 
Table -1: Incidence of Salivary Gland Swellings at Govt. Royapettah Hospital and KMC 
Hospital, Chennai 
Year 
Total No. of 
surgical 
admissions 
Total No. of 
salivary gland 
swellings 
Percentage 
November 2014 
to August 2015 
12361 50 0.4% 
 
 Total number of admission to Department of General Surgery and Surgical Oncology 
were 12361, 50 cases of salivary gland swellings were admitted during November 2014 to 
August 2015. This constitutes 0.4% of total admissions. 
Table – 2: Age Incidence of Salivary Gland Swellings 
Age Frequency Percent 
Below 20 6 12 
21-30 4 8 
31-40 15 30 
41-50 9 18 
51-60 6 12 
61-70 8 16 
71-80 2 4 
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In our study, age of the patients varied from 18 years to 80 years, Average age of the 
patient was 40 years. 
 The case of lowest age group i.e., 18 years was of non inflammatory swelling and the 
case of highest age i.e., 80 years was of tumor swelling. 
Graph 1: Showing Age Incidence 
 
 
 
 
 
 
 
 
 On descriptive statistical analysis, of age in year with HPE reports P value was found 
to be = 0.052, which was > 0.050 and hence P value was not significant. It indicates not 
significane between age group and HP reports in our study. 
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Table – 3:  Correlation of Sex with HPE Reports 
Age in years  Number (%)  
Histopathologic Examination Result 
 
Total  P value 
Pleomorphic 
Adenoma of 
Parotid 
Warthins 
Tumour of 
Parotid 
Adeno 
Carcinoma 
Parotid 
Retention 
Cyst 
Below 20 
  
  
Count 4 0 0 1 5 
0.052 
% within Age 
in years 80.0% .0% .0% 20.0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
14.8% .0% .0% 100.0% 15.2% 
21-30 
  
  
Count 1 0 0 0 1 
% within Age 
in years 100.0% .0% .0% .0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
3.7% .0% .0% .0% 3.0% 
31-40 
  
  
Count 8 1 0 0 9 
% within Age 
in years 88.9% 11.1% .0% .0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
29.6% 25.0% .0% .0% 27.3% 
41-50 
  
  
Count 6 0 0 0 6 
% within Age 
in years 100.0% .0% .0% .0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
22.2% .0% .0% .0% 18.2% 
51-60 
  
  
Count 2 2 0 0 4 
% within Age 
in years 50.0% 50.0% .0% .0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
7.4% 50.0% .0% .0% 12.1% 
61-70 
  
  
Count 5 1 0 0 6 
% within Age 
in years 83.3% 16.7% .0% .0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
18.5% 25.0% .0% .0% 18.2% 
71-80 
  
  
Count 1 0 1 0 2 
% within Age 
in years 50.0% .0% 50.0% .0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
3.7% .0% 100.0% .0% 6.1% 
Total 
Count 27 4 1 1 33 
% within Age 
in years 81.8% 12.1% 3.0% 3.0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
100.0% 100.0% 100.0% 100.0% 100.0% 
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Table – 4: Sex Incidence 
Sex No.of Patients  Percentage 
Male 17 34 
Female 33 66 
 
 
Graph 2: Correlation of Sex with HPE Reports 
 
 
 
 
 
 
  
In our study of, salivary gland swelling due to various causes, out of 50 cases 17(34%) cases 
was of male and 33(66%) cases of female. 
 On descriptive statistical analysis, of sex distribution with HPE reports P value was 
found to be = 0.232 (> 0.05) so not significant. 
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Table – 5: Correlation of Sex with HPE Reports 
Sex  Numbe (%)  
Histopathologic Examination Result 
Total  
P value 
Pleomorphic 
Adenoma of 
Parotid 
Warthins 
Tumour of 
Parotid 
Adeno 
Carcinoma 
Parotid 
Retention 
Cyst 
0.232 
Male 
 
 
Count 8 1 1 1 11 
% within Sex 72.7% 9.1% 9.1% 9.1% 100.0% 
% within 
Histopathologic 
Examination 
Result 
29.6% 25.0% 100.0% 100.0% 33.3% 
Female 
 
 
Count 19 3 0 0 22 
% within Sex 86.4% 13.6% .0% .0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
70.4% 75.0% .0% .0% 66.7% 
Total 
Count 27 4 1 1 33 
% within Sex 81.8% 12.1% 3.0% 3.0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
100.0% 100.0% 100.0% 100.0% 100.0% 
 
Table – 6: Mode of Clinical Presentation 
Mode No.of Cases Percentage 
Swelling  50 100.0 
Pain 26 52.0 
Fever 3 6.0 
Increased salivation 1 2.0 
Tenderness 28 56.0 
Fixity of swelling 7 14.0 
Ear lobe elevation 24 48.0 
Deep lobe involvement 5 10.0 
Facial nerve paralysis 3 6 
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Graph 3: Showing Mode of Clinical Presentation 
 
 
 
 
 
 
In our study, all cases presented with, symptoms of swelling (100%), 52% (26) 
presented with pain. 56% (28) presented with tenderness. Five cases were with deep lobe 
involvement (10%), 24 cases of ear lobe elevation (48%). Facial nerve paralysis occurred in 
three case (6%). 
Table – 7: Site for Various Salivary Gland Swellings 
No.of cases Parotid Submandibular Sublingual 
50 32 14 4 
% 64 28 8 
 
In our study, 64% (32 cases) were found in the parotid gland, 28% cases (14) in 
submandibular gland and 8% cases (4) in the sublingual gland. 
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Graph 4: Showing Sites of various Salivary Swellings 
 
 
 
 
 
 
 
 
Graph 5: Correlation of Site with HPE Reports 
 
 
 
 
 
 
 
 
 
 
 
 On the descriptive statisitical analysis of Gland Involvement with HP reports P value 
was found to be = to 0.000 (< .01) highly significant. Therefore correlation of Gland 
involvement with HP reports were highly significant. 
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Table – 8: Correlation of Site with HPE Reports 
Gland 
Involvement  Number (%)   
Histopathologic Examination Result 
Total  
P value 
Pleomorphic 
Adenoma of 
Parotid 
Warthins 
Tumour 
of Parotid 
Adeno 
Carcinoma 
Parotid 
Retention 
Cyst 
<0.001 
Parotid 
 
 
Count 21 4 1 0 26 
% within Gland 
Involvement 80.8% 15.4% 3.8% .0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
77.8% 100.0% 100.0% .0% 78.8% 
Submandibular 
Duct 
 
 
Count 6 0 0 0 6 
% within Gland 
Involvement 100.0% .0% .0% .0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
22.2% .0% .0% .0% 18.2% 
Sublingual Gland 
 
 
Count 0 0 0 1 1 
% within Gland 
Involvement .0% .0% .0% 100.0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
.0% .0% .0% 100.0% 3.0% 
Total 
Count 27 4 1 1 33 
% within Gland 
Involvement 81.8% 12.1% 3.0% 3.0% 100.0% 
% within 
Histopathologic 
Examination 
Result 
100.0% 100.0% 100.0% 100.0% 100.0% 
 
Table – 9: Various Causes of Salivary Gland Swellings 
Lesions No.of Cases Percentage 
Noninflammatory non neoplastic 18 36.0 
Neoplastic 32 64.0 
Total 50 100.0 
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Graph 6: Showing Causes of Salivary Swellings 
 
 
 
 
 
 
 
  
In our study, out of 50 cases, neoplastic lesions of 64.0% (32 cases) and non 
inflammatory non neoplastic lesions of 36% (18 cases) were seen. 
Table – 10: Incidence of Non Inflammatory, Non Neoplastic Swellings 
Lesions No.of Cases Percentage 
Sialolithiasis 14 77.8 
Ranula 3 16.7 
Retention cyst 1 5.6 
 
Graph 7: Showing Incidence of Non Inflammatory, Non Neoplastic Swellings 
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 In our study, out of 19 cases, 14 (78.9%) were sialolithiasis and 3 cases (21.1%) of 
sublingual ranula and 1 retention cyst. 
Table – 11: Site Involvement in Non Inflammatory Non Neoplastic Swellings 
No.of Cases 
Parotid Sub mandibular Sublingual 
R L R L R L 
18 - - 6 8 4 - 
 
 In our study, 6 of cases of sialolithiasis were in right submandibular gland, 8 of cases 
in the left submandibular gland and 4 cases of ranula were seen in right sublingual gland 
only. 
Table – 12: Incidence of Benign and Malignant Salivary Gland Tumours 
Lesions No.of Cases Percentage 
Benign 31 96.88% 
Malignant 1 3.1% 
 
 In our study, out of 32 salivary tumors, 93.75% (30) and were benign and 6.25% (2) 
were malignant. 
Table – 13: Incidence of Various Salivary Glands Tumours 
Lesion No. of Cases Percentage 
Pleomorphic adenoma 27 84 
Warthin tumour 4 14 
Adenoid cystic carcinoma 1 2 
Total 32 100 
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 In our study, out of 25 salivary gland tumors, plemorphic adenoma was 84% (27), 
14% (4) of warthin tumour and One case (2%) of adenoid cystic carcinoma. 
 
Table – 14: Correlation of FNAC and Histopatology 
Lesion No. of Cases FNAC (%) BOIPSY (%) 
Pleomorphic adenoma 27 100 100 
Warthin tumour 4 100 100 
Adenoid cystic Ca. 1 100 100 
 
 
 In our study, the accuracy of FNAC was 100% in case of benign salivary gland 
tunours, for Pleomorphic adenoma, Warthin tumour, Adenoid cystic Ca. 
 
Table – 15: Surgical Procedures Adopted for Various Salivary Gland Swellings 
 
Procedures No. of Cases Percentage 
Excision of submandibular gland 15 30% 
Superficial parotidectomy 26 52% 
Total Parotidectomy 5 10% 
Excision ranula 3 6% 
Retention cyst 1 2% 
Total 50 100 
  
In our study, surgery was the treatment for all cases of tumors. Superficial  
parotidectomy was done in all the 26 cases of parotid tumour (52%) without deep lobe 
involvement and total parotidectomy was done in 5 cases (10%) with deep lobe involvement. 
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In all the cases of submandibular gland lesions, excision of submandibular gland was done. 
Excision of the sublingual gland was done in 3 cases of ranula and 1 retention cyst excision. 
Table – 16: Post Operative Complications 
Nature of Complications No. of Patients Percentage 
Facial nerve paralysis 3 37.5 
Wound infection 5 62.5 
 
Post operative complications is my study of 50 cases were low. 3 cases of facial nerve 
paralysis occurred after parotid tumour surgery and wound infection was noticed in 5 cases. 
Graph 8: Correlation of Post Operative Complications with HPE Reports 
 
 
 
 
 
 
 
On correlation of Occupation with HP reports P value = 0.458 (> .05) and hence not 
significant. 
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Table – 17: Occupation 
Occupation Frequency Percent 
 AGRI 5 10.0 
  COOLIE 3 6.0 
  EMPL 1 2.0 
  FARMER 7 14.0 
  H.W 23 46.0 
  STU 6 12.0 
  VENDOR 5 10.0 
 
Graph 9: Occupation 
 
 
 
 
 
 
On the bases of occupation house wife were more commonly affected (46%) followed 
by farmers (14%). Least common were employees 2%. 
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Graph 10: Correlation of Duration of Swelling in years with HPE Reports 
 
 
 
 
 
 
 
 
 
 
On descriptive analysis of duration of swelling with HPE reports P value = 0.161                 
(> .05) therefore not significant. On distributive analysis 1 to 3 years swelling were 
commonets followed by 3 to 5 years. Upto one year was less common. 
Graph 11: Correlation of Clinical Diagnosis with HPE Reports 
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On descriptive analysis of Clinical Diagnosis with HPE reports P value = 0.000                 
(< .01) therefore highly significant. Therefore there is strong association between clinical 
diagnosis and HP reports. 
Graph 12: Correlation of Surgery done with HPE Report 
 
 
 
 
 
 
 
 
 
 
On descriptive analysis of Surgery with HPE reports P value = 0.000 (< .01) therefore 
highly significant. Therefore there is strong association between Surgery done and HP 
reports. 
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DISCUSSION 
 Comparison of our present series of 50 cases with various series of other authors. 
Table – 18: Incidence per Year of Salivary Gland Tumours in Different Series 
Series 
No.of 
tumours 
Period of 
study 
No. of cases per 
year 
Potdaretar120 1969 188 10 18 
Gupta et al121 1975 113 21 05 
Khazanchi et al122 1988 88 6 15 
Fennetal123 1982 57 15 04 
Renehan et al123 1996 1194 45 27 
Present study 32 0.9 28 
 
 In our series, mean incidence is 28 cases per year. This incidence correlates with most 
of studies by other authors in the above date. 
 
Table – 19: Incidence of Sialolithiasis in Various Studies 
Series No. of cases parotid Sub mandibular Sub lingual 
Antognini et al125 1971 396 8.3 91.4 0.3 
Pizzirani et al126 1985 102 7.8 92.2 - 
J. Lustmann et al 127 1990 245 4.5 94.3 0.4 
Present study 14 - 100 - 
 
 In our study, incidence percentage of sialolithiasis i.e., 14 cases were found in 
submandibular gland which co-relates with most of the authors in the above table series. 
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Table – 20: Frequency of Benign and Malignant Salivary Tumours in Different Series 
Series  
No.of 
tumors 
Benign Malignant 
Foote et al128 1954 730 68.30% 31.70% 
Skolniketal129 1977 435 59340% 30.60% 
Khazanchi et al122 1988 88 63.60% 36.40% 
Renehan et al124 1996 1194 80.00% 0.00% 
Present study 32 96.8% 3.1% 
 
 In accordance with the observation in other series, the benign tumors predominate in 
our study. 
Table – 21: Location of Various Tumours in Different Series 
Series  Parotid Submandibular Sublingual 
Budhraja et al 130 1974 82.10% 12.40% 5.5% 
Sharkey F.E. et al1311977 80.50% 6.00% 9.0% 
Everson et al67 1985 72.90% 10.70% 16.4% 
Renehan et al124 1996 91.00% 4.0% 5% 
Present study 100% - - 
 
 In our study, all the salivary gland tumors were observed in parotid gland. 
Comparative study was in accordance to Renehan et al. Tumours of sublingual glands are  
extremely rare and no cases were recorded with submandibular gland, because of, small 
number of cases and short study period. 
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Table – 22: Incidence of Superficial and Deep Lobe Involvement of Parotid Gland 
Tumours in Different series 
Series 
Total No. of 
cases 
Superficial  Deep 
H. Leverstein et al., 1997132 245 192(78.3%) 54(22%) 
H. Laccourreve et al., 133 1994 229 118(51.5%) 111(48.4%) 
Present Series 32 27(88.46%)  5(11.53%) 
 
 In our study, out of 32 parotid tumours, 27 (88.46%) were seen in superficial lobe of 
parotid and 5 (11.53%) in deep lobe which is in accordance with the H. Leverstein et al., 
series. 
Table – 23: Average Age Incidence of Salivary Gland Tumours in Different Series 
SERIES 
Average age in years 
Benign Malignant 
Potdar etal120 1969 40 49 
budhrajetal1301947 41 41 
Skolnik et al129 1977 45 56 
Khazanchi et al1221988 44 50 
Renehan et al124 1996 55 59 
Present study 47 80 
 
 In our series of salivary gland tumors out of 32 cases, 31 cases were benign with 
mean age 45 and one case was malignant of 80 years age. 
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The results observed in our study are consistent with other studies shown in the table. 
 In our study of 50 cases of salivary gland swelling, shows that, surgery is the 
treatment of choice in all cases of salivary gland swellings. FNAC plays an important role in 
the diagnosis of salivary gland tumors and accuracy rate was 100% in our series. 
 In our study, there was no recurrence and nil mortality. 
 Benign swelling of the salivary gland found in lower decade of life, where as, 
malignant swelling was found in 8th decade of life, which correlates with many authors in 
other series. 
Table – 24: FNAC Comparison with Pathologic Diagnosis in Different Series 
Series Benign Malignant 
Frable and Frable 1982 134 91% 92% 
Spiro RH et al., 1974135 98% 93% 
Present Study 100% 100% 
 
 In our study of 50 cases, FNAC was in accordance with the other author’s series 
shown in above table. 
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CONCLUSION 
Following the study of 50 cases of salivary gland swellings, the following conclusions 
can be made.  
 Diagnosis of the salivary gland tumors must be considered in any patient presenting 
with salivary gland swelling  
 Salivary gland swelling occur more commonly in 3rd and 4th decades of life and seen 
most common in females 
 Neoplastic salivary gland swellings were more common than non inflammatory 
swellings.  
 Sialolithiasis is the predominant non inflammatory swelling. 
 Sialolithiasis occur more commonly in the submandibular salivary glands.  
 Salivary gland tumors occur more commonly in the parotid gland, most often benign, 
pleomorphic adenoma constitute majority of all neoplasm  
 History and physical examination complement FNAC and help in diagnosis. FNAC 
has good accuracy in diagnosing salivary gland swellings.  
 Surgery is the main modality of treatment in salivary gland sialolithiasis. Most 
commonly done surgery is excision of submandibular salivary gland.  Most 
commonly done surgery is superficial parotidectomy.  
 Since most malignant tumors are  asymptomatic and long standing benign tumors can 
undergo malignant change, community awareness and early referral is necessary, as 
prognosis is good if treated early.  
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SUMMARY 
 The clinical material in this study includes the details of 50 cases of salivary gland 
swellings admitted in surgical units, surgical oncology of Govt. Royapetah Hospital and 
KMC hospital Chennai from Nov 2014 to Aug 2015.  
 The incidence of salivary gland swellings is highest in the 3rd and 4th decade of life. 
Benign tumors were more common in 20 - 50 years and malignancy was seen in one 
patient of age 80 years.  
 In this series, 17 patients were male (34%) and 33 (66%) patients were female. With male 
to female ratio of 1:1.9  
 Commonest of salivary swellings was seen in parotid gland with 32 cases (64%)  
 In this series, 18 cases (36 %) of salivary swellings was due to non-inflammatory and 
non-neoplastic swellings and 32 cases (64%) was due to neoplatic swellings. 
 Incidence of non-inflammatory non neoplastic swellings was most often seen in 
submandibular salivary glands. 80 % (14) were seen affecting the submandibular gland 
and 20 % (4) was seen affecting the sublingual glands.  
 Incidence of tumours was highest in the parotid. Incidence of benign tumours is 31 
(96.8%) and malignant tumors are 1(3.1%). Pleomorphic adenoma is the commonest 
benign tumour and Adenoid cystic carcinoma was the only malignant tumour. 
 Patients presented with history of swellings varying from 4 months  to 5 years. Swelling 
is the most common symptom. Pain was the second most common symptoms. Pain was 
noticed in 52% of the cases  and tenderness was noticed in 56% of the cases.  
 Patient with malignant tumor had other symptoms in addition to the swelling, like pain, 
facial asymmetry due to facial nerve paresis.  
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 Final diagnosis was arrived at by Physical examination and FNAC. FNAC is the reliable 
and sensitive tool for diagnosing salivary gland tumours. There was an overall diagnostic 
accuracy of 100%  
 Surgery is the treatment in all the cases of salivary swelling. Out of 32 cases of parotid 
tumour. Superficial parotidectomy was done in 28 cases (87.5%) and total parotidectomy 
for 4 cases (12.5%). For all the submandibular gland lesions sialadenectomy was done. 
Sublingual gland excision was carried out for 3 cases of ranula and 1 retention cyst 
excision. 
 Wound infection was the major complication with 5 cases (62.5%) and three cases  of 
facial nerve paralysis (37.5%) was observed. 
 Out of 50 cases, 18 cases (36%) were due to non-inflammatory and non-neoplastic 
swellings. Out of which 14 cases (77.8%) was due to submandibular sialoloithiasis and 3 
cases (16.7%) was due to ranula of the sublingual glands and 1(5.6%) case of sublingual 
retention cyst. 32 Cases (64%) were due to salivary gland tumours. Out of 32 tumours, 
Pleomorphic adenoma is seen in 27 cases (84.4%), Warthin's tumour is seen in 4 cases 
(12.5%) and one case of adenoid cystic carcinoma (3.1%). 
 With proper diagnosis and appropriate treatment. Salivary gland swelling can be cured 
with almost 100%.  
 Successful management of the salivary gland neoplasm depends on accurate clinical 
assessment and diagnosis, with appropriate use of fine needle aspiration and CT or MR 
imaging. Moreover, knowledge of the particular behaviour of each tumor type guides the 
development of an appropriate treatment plan for each individual patient.  
 There was no mortality in our study of 50 cases after follow up for 1 months to 10 
months. But follow up period was inadequate as salivary gland tumours are known for 
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their late recurrence. The adequacy of treatment cannot be commented because of short 
period of follow up.  
 The study group in this series is small, as compared to large series in western literature. 
So statistical data in this series may not represent the actual data quoted in western 
literature.  
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ANNEXURE - 1 
PROFORMA 
NAME :  DATE OF ADMISSION : 
AGE :  DATE OF OPERATION : 
OCCUPATION :  DATE OF DISCHARGE : 
ADDRESS :  I.P. No.  : 
   INCOME : 
 
PROVISIONAL DIAGNOSIS: 
COMPLAINTS WITH DURATION:  
HISTORY OF PRESENT ILLNESS: 
• Swelling  
- Onset  
- Site  
- Duration 
- Rate of growth 
- Pain 
-  Relation to food  
• Ulceration and discharge  
• H/o Fever 
• H/o dryness of Mouth  
• H/o Trauma 
• H/o Difficulty in the movement of jaw 
• H/o Any other swelling in the opposite side 
• H/o Appetite and weight  
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PAST HISTORY:  
H/o any similar complaints in the past  
H/o collagen disease  
 
FAMILY HISTORY:  
H/o salivary gland enlargement in the family  
H/o Diabetes, Hypertension, Collagen disease etc.  
PERSONAL HISTORY: DIET   APPETITE   SLEEP 
BOWEL  MICTURITION  
SMOKING  CHEWING  ALCOHOLIC  
 
GENERAL PHYSICAL EXAMINATION:  
BUILT   NOURISHMENT   PALLOR 
CYANOSIS   JAUNDICE    CLUBBING 
GENERALISED LYMPHADENOPATHY  
TEMP:  PULSE:   RESP.   RATE :   B.P.: 
 
LOCAL EXAMINATION:  
INSPECTION: 
- Number  
- Site 
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- Shape  
- Size 
- Surface 
- Borders  
- Skin over the swelling  
- Ear Lobule raised/not raised  
- Fistula and its position over the gland or duct  
- Movements of the jaw  
PALPATION:  
- Temperature  
- Tenderness 
- Size, Shape  
- Extent 
- Surface, Borders 
- Fistula 
- Mobility 
- Fixity to overlying skin Relation to masseter muscle 
- Plane of the swelling  
- Jaw movements 
- Facial and lingual nerve palsy 
- Regional lymph nodes  
INTRAORAL EXAMINATION:  
- Oral Hygiene Caries Tooth Sepsis 
- (Cleaning material used) 
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- (Whether gargling after each meal) 
- Bulging or fullness in the floor of the mouth or in the 
- Supra-tonsillar region. Opening of the parotid duct 
- Opening of the Wharton's duct 
- Bi-digital examination  
- Any other swelling in the oral cavity  
 
SYSTEMIC EXAMINATION:  
- Cardiovascular system  
- Respiratory system  
- GIT Liver 
- Genitourinary system  
- CNS  
- Bones  
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INVESTIGATIONS: 
- Hb%    TC   DC   ESR  
- Blood Sugar   Blood Urea  Serum Creatinine 
- Urine:   Albumin  Sugar:   Microscopy: 
- X-ray chest/Screening chest 
- X-ray mandible 
- Sialography  
- Radio-Isotope Scan  
- FNAC  
 
CLINICAL DIAGNOSIS:  
TREATMENT  -  Surgical/radiotherapy/Chemotherapy/Survey + 
Radiotherapy  
SURGICAL 
Pre -operative treatment  
Type of operation  
Findings at operation  
Post- Operative period- Wound infection, Fistula,  
Facial paralysis,  
Any other  
BIOPSY REPORT:  
FOLLOW-UP:  
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Ra xg;g[jy; fojk;  
Ma;t[ bra;ag;gLk; jiyg;g[ : ckpH;ePh; Rug;gp tPf;fk; gw;wpa Ma;t[ 
      (Clinical and Pathological  
study of Salivary Gland Swellings) 
Ma;t[ bra;ag;gLk; Jiw : bghJ mWit rpfpr;ir kw;Wk; 
      g[w;W  neha;mWit rpfpr;irj; Jiw 
kUj;Jtkid    : muR ,uhag;ngl;il  kUj;Jtkid 
      fPH;ghf;fk; muR kUj;Jtkid kw;Wk; 
      fy;Y}hp /   brd;id 
g=;F bgWgthpd; bgah;  : 
g=;F bgWgthpd; taJ  : 
g=;F bgWgthpd; kUj;Jtkid : 
vz; 
g=;F bgWgth; ,jid ( √) Fwpf;ft[k;. 
1. ,e;j kUj;Jt Ma;tpd; tptu=;fs; vdf;F bjspthf tpsf;fg;gl;lJ.  vd;Dila 
re;njf=;fis nfl;ft[k;/ mjw;fhd tpsf;f=;fis bgwt[k; tha;g;g[ mspf;fg;gLk; vd 
mwpe;J bfhz;nld;. 
2. ehd; ,e;j Ma;tpy; jd;dpr;irahf jhd; g=;nfw;fpnwd;. ve;j fhuzj;jpdhnyh ehd; ,e;j 
Ma;tpy; ,Ue;J tpyf Mirg;gl;lhy; ve;j jl=;fYk; ,d;wp tpsfyhk; vd;Wk; mwpe;J 
bfhz;nld;. 
3. ,e;j Ma;t[ rk;ke;jkhfnth/ ,ij rhh;e;j nkYk; Ma;t[ nkw;bfhs;Sk; bghGnjh 
,e;j Ma;tpy; g=;F bgWk; kUj;Jth; vd;Dila kUj;Jt mwpf;iffis 
ghh;g;gjw;F vd; mQkjp njitapy;iy vd mwpfpnwd;. 
4. ,e;j Ma;tpy; g=;F bfhs;s ehd; Ra epidnthL KG rk;kjj;njhLk; xg;g[jy; 
mspf;fpnwd;. 
g=;F bgWgthpd; bgah; :   Ma;thshpd; bgah; : 
g=;F bgWgthpd;     Ma;thshpd;  
ifbahg;gk;     :     ifbahg;gk;  : 
       njjp  : 
       ,lk;   : 
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ABBREVIATIONS 
IP NO      IN PATIENT NUMBER      
STU      STUDENT 
OCCU      OCCUPATION                                                  
EMPL      EMPLOYEE 
DURN.SWELL    DURATION OF SWELLING                
AGRI      AGRICULTURIST 
GROWTH RAT    GROWTH RATE                                 
R-PR      RIGHT  SIDE PAROTID 
H/O SALIV     HISTORY OF SALIVATION                   
L-PR      LEFT SIDE PAROTID 
GL INVOLV     GLAND INVOLVEMENT                       
R-SMD     RIGHT SIDE SUBMANDIBULAR DUCT 
SIZE CMS     SIZE IN CENTIMETERS                             
L-SMD     LEFT SIDE SUBMANDIBULAR DUCT 
T      TENDERNESS                                                      
R-SL      RIGHT SIDE  SUBLINGUAL GLAND 
M      MOBILITY                                                          
L-SL      LEFT SIDE SUBLINGUAL GLAND 
C      CONSISTENCY                                                     
H      HARD 
F      FIRM 
S      SOFT 
7 CN PALSY     7TH CRANIAL NERVE PALSY             
SL.NO      SERIAL NUMBER 
REL      RAISED EAR LOBULE                                         
M      MALE 
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F      FEMALE  
SKIN CH     SKIN CHANGES                                       
YRS      YEARS 
D OPEN     DUCT OPEN                                                 
N      NORMAL 
D PAR     DEEP LOBE OF PAROTID INVOLVEMENT 
ROC      RADIO OPAQUE CALCIFICATION 
LN      LYMPH NODE                                                    
PLA.PR     PLEOMORPHIC ADENOMA OF PAROTID 
XRAY MND     X RAY MANDIBLE                               
WT.PR     WARTHINS TUMOUR OF PAROTID 
SIALO     SIALOGRAM                                                  
ACA.PR     ADENO CARCINOMA PAROTID 
FNAC      FINE NEEDLE ASPIRATION CYTOLOGY 
SM.SIAL     SUBMANDIBULAR SIALOLITHIASIS 
C DIAGNO     CLINICAL DIAGNOSIS                          
RET.CYST     RETENTION CYST 
SUR      SURGERY DONE                                              
RANULA.SL     RANULA OF SUBLINGUAL GLAND 
HPE      HISTOPATHOLOGIC EXAMINATION 
RESULT.    
SUP.PARO     SUPERFICIAL PAROTIDECTOMY. 
F.UP      FOLLOW UP                                                    
SMD.EX     SUB MANDIBULAR GLAND EXCISION 
H.W      HOUSE WIFE                                                  
TOT.PARO     TOTAL PAROTIDECTOMY 
CY      CYSTIC 
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